
<html lang="en"     class="pb-page"  data-request-id="64a18683-4586-4e13-b756-836f6d630f46"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-16;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm800453a"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Redesigning Kinase Inhibitors to Enhance Specificity" /></meta><meta name="dc.Creator" content="Alejandro  Crespo" /></meta><meta name="dc.Creator" content="Xi  Zhang" /></meta><meta name="dc.Creator" content="Ariel  Fernández" /></meta><meta name="dc.Description" content="Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding un..." /></meta><meta name="Description" content="Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding un..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 5, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800453a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800453a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800453a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800453a" /></link>
        
    
    

<title>Redesigning Kinase Inhibitors to Enhance Specificity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800453a" /></meta><meta property="og:title" content="Redesigning Kinase Inhibitors to Enhance Specificity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0003.jpeg" /></meta><meta property="og:description" content=" Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding unexpected side effects. Thus, the use of promiscuous drugs is likely to introduce dangerous clinical uncertainties. Here, we show how to rationally redesign two promiscuous kinase inhibitors, staurosporine (7) and EKB-569 (8), with the goal of turning them into more selective ligands. This problem is addressed by exploiting a structure-based selectivity filter for specificity: the pattern of packing defects in the target. These singularities, called dehydrons, are solvent-exposed intramolecular hydrogen bonds that may be protected by drugs upon association and are not conserved across protein families. Our redesigned compounds possess a significantly focused activity, as experimentally corroborated in high-throughput screening assays. Thus, our design strategy proves to be operative to reduce the inhibitory impact of promiscuous kinase ligands, enhancing their safety as therapeutic agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800453a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800453a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800453a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800453a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800453a&amp;href=/doi/10.1021/jm800453a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 4890-4898</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800156z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8000423" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Redesigning Kinase Inhibitors to Enhance Specificity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alejandro++Crespo">Alejandro Crespo</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xi++Zhang">Xi Zhang</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ariel++Fern%C3%A1ndez">Ariel Fernández</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Bioengineering, Rice University, Houston, Texas 77005, Program in Applied Physics, Rice Quantum Institute, Rice University, Houston, Texas 77005</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (713)348-3681. Fax: (713)348-3699. E-mail: <a href="/cdn-cgi/l/email-protection#b0d1c2d9d6d5c2f0c2d9d3d59ed5d4c5"><span class="__cf_email__" data-cfemail="3e5f4c57585b4c7e4c575d5b105b5a4b">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Bioengineering, Rice University.</div><div class="corresp-fn" id="afn2">‡Program in Applied Physics, Rice Quantum Institute, Rice University.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800453a&amp;href=/doi/10.1021%2Fjm800453a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 4890–4898</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 5, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 April 2008</li><li><span class="item_label"><b>Published</b> online</span>5 August 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 August 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800453a" title="DOI URL">https://doi.org/10.1021/jm800453a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4890%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlejandro%2BCrespo%252C%2BXi%2BZhang%252C%2BAriel%2BFern%25C3%25A1ndez%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D16%26contentID%3Djm800453a%26title%3DRedesigning%2BKinase%2BInhibitors%2Bto%2BEnhance%2BSpecificity%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4898%26publicationDate%3DAugust%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800453a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2487</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800453a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Redesigning Kinase Inhibitors to Enhance Specificity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alejandro&quot;,&quot;last_name&quot;:&quot;Crespo&quot;},{&quot;first_name&quot;:&quot;Xi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ariel&quot;,&quot;last_name&quot;:&quot;Fernández&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;4890-4898&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800453a&quot;},&quot;abstract&quot;:&quot;Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding unexpected side effects. Thus, the use of promiscuous drugs is likely to introduce dangerous clinical uncertainties. Here, we show how to rationally redesign two promiscuous kinase inhibitors, staurosporine (7) and EKB-569 (8), with the goal of turning them into more selective ligands. This problem is addressed by exploiting a structure-based selectivity filter for specificity: the pattern of packing defects in the target. These singularities, called dehydrons, are solvent-exposed intramolecular hydrogen bonds that may be protected by drugs upon association and are not conserved across protein families. Our redesigned compounds possess a significantly focused activity, as experimentally corroborated in high-throughput screening assays. Thus, our design strategy proves to be operative to reduce the inhibitory impact of&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800453a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800453a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800453a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800453a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800453a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800453a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800453a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800453a&amp;href=/doi/10.1021/jm800453a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800453a" /></input><a href="/doi/pdf/10.1021/jm800453a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800453a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800453a%26sid%3Dliteratum%253Aachs%26pmid%3D18680272%26genre%3Darticle%26aulast%3DCrespo%26date%3D2008%26atitle%3DRedesigning%2BKinase%2BInhibitors%2Bto%2BEnhance%2BSpecificity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D16%26spage%3D4890%26epage%3D4898%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding unexpected side effects. Thus, the use of promiscuous drugs is likely to introduce dangerous clinical uncertainties. Here, we show how to rationally redesign two promiscuous kinase inhibitors, staurosporine (<b>7</b>) and EKB-569 (<b>8</b>), with the goal of turning them into more selective ligands. This problem is addressed by exploiting a structure-based selectivity filter for specificity: the pattern of packing defects in the target. These singularities, called <i>dehydrons</i>, are solvent-exposed intramolecular hydrogen bonds that may be protected by drugs upon association and are <i>not</i> conserved across protein families. Our redesigned compounds possess a significantly focused activity, as experimentally corroborated in high-throughput screening assays. Thus, our design strategy proves to be operative to reduce the inhibitory impact of promiscuous kinase ligands, enhancing their safety as therapeutic agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The use of small-molecule inhibitors of protein function is one of the most efficient ways to treat human disease and malignancy.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> In this regard, protein kinases, the essential signal transducers, have become important targets in molecular cancer therapy.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> However, most protein targets of therapeutic interest have surviving paralogues, i.e., proteins that share a common ancestor with the target and have diverged after speciation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In particular, kinases are lumped up into families, which typically share a very similar fold and specific structural features.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> This structural conservation is often responsible of unexpected cross reactivities,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> yielding uncertain or even life-threatening side effects.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a></div><div class="NLM_p">Although there is no clear correlation between anticancer activity and specificity, promiscuous inhibitors are obviously more prone to yield side effects than selective drugs. Even the most successful anticancer drug imatinib (STI571, <b>1</b>),<a onclick="showRef(event, 'ref3 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref13">(3, 13)</a> with an activity profile limited to 5 primary kinases (Abl, C-Kit, Lck, PDGFR, and CSF1R),<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> has shown to be potentially cardiotoxic.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Moreover, the more promiscuous anticancer kinase inhibitors<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> sunitinib (SU11248, <b>2</b>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and sorafenib (Bay 43-9006, <b>3</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> have also been found to be cardiotoxic, and to an even larger extent than imatinib.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The other commercial kinase inhibitors (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) dasatinib (BMS-354825, <b>4</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> erlotinib (OSI-774, <b>5</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and gefitinib (ZD1839, <b>6</b>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> have also a broad activity profile.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0011.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Structures of Commercial Anticancer Drugs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The therapeutic use of promiscuous inhibitors may be potentially hazardous unless a rational strategy to control their specificity is adopted. Such control may be achieved if we can identify selectivity filters in the target, i.e., structural features that are unique to the target, and chemical modifications to the drug that promote interactions with such unique features. Thus, much of the cross reactivity may be removed by redesign guided by the identification of structural features that promote promiscuity and selectivity filters that enable target discrimination.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a></div><div class="NLM_p">A selectivity filter of broad applicability has been recently identified: the packing defects of soluble proteins.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23-27)</a> These defects consist of solvent-exposed intramolecular backbone hydrogen bonds and constitute vulnerabilities arising from imperfections in side chain packing. These structural singularities, called dehydrons,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> are targetable-sticky spots because they promote their own further dehydration as a means to strengthen and stabilize the underlying amide-carbonyl electrostatic interaction.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23-27)</a> Dehydrons have been turned into an operational selectivity filter for two reasons: (i) they may be targeted by drugs that further wrap them (protect from water attack) by bringing nonpolar groups to their proximity upon association<a onclick="showRef(event, 'ref19 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref19 ref28 ref29">(19, 28, 29)</a> and (ii) they are not conserved across paralogues.<a onclick="showRef(event, 'ref6 ref30'); return false;" href="javascript:void(0);" class="ref ref6 ref30">(6, 30)</a> In this work, we report on a rational redesign of promiscuous inhibitors to exogenously wrap nonconserved dehydrons with the goal of enhancing their target-discriminatory power.</div><div class="NLM_p">In principle, most kinase inhibitors can be turned into selective wrappers of dehydrons through minimal chemical modification that preserve the generic chemotype. Thus, relevant kinase inhibitors with considerable cross reactivities such as staurosporine (<b>7</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (inhibiting 87% out of the 290 kinases screened with <i>K</i><sub>D</sub> < 3 μM),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> sunitinib (57%), dasatinib (28%), EKB-569 (<b>8</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (18%), sorafenib (18%), erlotinib (15%), gefitinib (7%), or imatinib (6%) may in principle be turned into drugs with enhanced specificity through wrapping redesign. The generic strategy consists of modifying the parental compound to turn it into a wrapper of unique dehydrons while also removing potential sources of cross reactivity. These arise because ligand groups are often engaged in interactions with groups on the backbone or on side chains that are invariant across the target family.</div><div class="NLM_p">To test the target-discriminatory power of wrapping redesign, we focus in this work on a major challenge arising thereof: the re-engineering of promiscuous inhibitors. First, we report on the redesign of staurosporine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), the most promiscuous kinase inhibitor known,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> to elicit an inhibitory impact with enhanced specificity. Our redesign introduces a single wrapping modification to target one of the least conserved kinase dehydrons. The resulting ligand <b>9</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) possesses a significantly more focused impact than the parental compound, as corroborated in high-throughput screening assays. We also report on the successful cleaning of the “dirty” inhibitor <b>8</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). This is carried out by removing the promiscuity-promoting elements in the compound while appending a nonpolar group that wraps a unique dehydron of the primary target of <b>8</b>, the epidermal growth factor receptor (EGFR) kinase. The experimental high-throughput screening assay of the wrapping compound <b>10</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) confirms its considerably focused activity profile.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0012.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Chemical Structures of Compounds <b>7</b> and <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0001.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Structures of Compounds <b>8</b> and <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The solution to the challenging design problems presented in this work singles out the wrapping redesign as a paradigm shifter in the engineering of highly selective inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Staurosporine Redesign</h3><div class="NLM_p">Staurosporine is the most cross-reactive kinase inhibitor known to date.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> It binds tightly (<i>K</i><sub>D</sub> < 3 μM) to ∼90% of the 119 (or 290 in the latest assay) human kinases screened through phage-display ATP-competitive assays.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Such levels of cross reactivity make it impossible to envision staurosporine as a therapeutic agent. Thus, despite its inhibitory potency, staurosporine is solely regarded as a research compound.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Staurosporine is a natural competitive inhibitor that binds to the ATP pocket of almost all kinases in the active conformation (the activation loop is fully extended and exposed to solvent).<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> To illustrate its binding mode, the crystal structure of the EGFR kinase in complex with staurosporine is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>). Staurosporine has a larger solvent-accessible surface area than ATP (360 Å<sup>2</sup> vs 323 Å<sup>2</sup>, respectively),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and it is a more rigid molecule, hence reducing the entropic penalty upon association. The high promiscuity of this inhibitor is due to the numerous contacts it makes (it is a large and rigid nonpolar molecule) with conserved polar and hydrophobic groups of protein kinases.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> For example, it makes strong van der Waals interactions with residues framing the ATP pocket such as L718, G719, F723, V726, A743, K745, T790, L792, M793, G796, S797, and L844. Staurosporine also forms two hydrogen bonds with the conserved backbone atoms of residues in the nucleotide-binding loop: Q791:<i>O</i>-Pyrrol:N6 and M793:<i>N</i>-Pyrrol:O5 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These residues are also involved in intermolecular hydrogen bonds with ATP. These extensive interactions with conserved regions make the re-engineering of staurosporine a challenging problem.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ribbon representation of EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue) in complex with staurosporine. Relevant structural features that frame the ATP-pocket (white circle) are depicted for clarity: nucleotide-binding loop (red), P-loop (orange), αC-helix (yellow), catalytic loop (green), and activation loop (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Induced-fit conformation of the ATP-binding pocket of EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue) generated when crystallized with staurosporine. The ligand forms two hydrogen bonds with the conserved backbone atoms of residues in the nucleotide-binding loop (Q791 and M793) and hydrophobic interactions with residues framing the pocket (gatekeeper: T790). EGFR kinase has seven dehydrons (green virtual bond joining α-carbons) within its binding pocket: G721-F723 and G721-G724 in the P-loop, R776-Q791, M793-G796, P794-G796, and G796-V845 in the nucleotide-binding loop, and D855-G857 in the activation loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To redesign staurosporine through a wrapping modification, we compare all 37 PDB structures of kinases in complex with ligands that share the same indolo[2,3-<i>a</i>]pyrrolo[3,4-<i>c</i>]-carbazole chemotype (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>). The EGFR-staurosporine complex has seven dehydrons within the ATP pocket: G721-F723 and G721-G724 in the P-loop, R776-Q791, M793-G796, P794-G796, and G796-V845 in the nucleotide-binding loop, and D855-G857 in the activation loop (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). From these seven, dehydrons R776-Q791, M793-G796, and D855-G857 are potentially more accessible to a wrapping modification of staurosporine (at least one α-carbon of the residues paired by the dehydron is within 7 Å from any atom of the ligand). A comparative wrapping analysis of the 37 aligned structures reveals that dehydron R776-Q791 is the least conserved and more easily accessible to a wrapping modification (generally methylation) in this structural assortment. This dehydron is conserved in 8 out of the 37 kinase structures, ABL1, EGFR, GSK3β, LCK, MAP3K5, MAP3K17, PTK2, and SRC (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), whereas dehydrons M793-G796 and D855-G857 are conserved in 9 and 12 structures, respectively. Thus, dehydron R776-Q791 may be targeted by wrapping it through a specific methylation of staurosporine (compound <b>9</b>) at the imide N6-position of the pyrrol ring (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>).<a onclick="showRef(event, 'ref31 ref33 ref37'); return false;" href="javascript:void(0);" class="ref ref31 ref33 ref37">(31, 33, 37)</a> This modification is mostly useful because will also remove one conserved hydrogen-bond interaction, increasing specificity. Thus, by redesigning staurosporine to turn it into a wrapper of the R776-Q791 dehydron in EGFR, we can significantly restrict its inhibitory impact to the 8 kinases that share the dehydron at the aligned position (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The bacteriophage high-throughput screening of <b>9</b> is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>: <i>only 26 kinases representing 12% of the 220 kinases assayed have significant affinity for the ligand. This percentage hit signals a massive enhancement in selectivity when compared with the 88% of the parental compound.</i> Most significantly, our structure-based prediction of affinity based on the presence or absence of the dehydron at the aligned position includes five hits (ABL1, EGFR, LCK, PTK2, and SRC), only one false positive (MAP3K5) and not a single false negative over the 18 instances (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) where packing prediction can be contrasted with experiment. These results reveal ∼94% of accuracy in the prediction. The other hits of <b>9</b> are: AAK1, ABL1 (H396P), ABL1 (T315I), ABL1 (Y253F), CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMKK1, CAMKK2, CSF1R, FLT3, KIT, KIT (D816V), LOK, MARK2, PAK6, PDGFRA, PDGFRB, PTK2B, and SLK. For these cases, we either do not have a crystal structure of the protein or the protein is crystallized in complex with a ligand other than staurosporine and hence with a different induced fit. However, all these hits correspond to staurosporine targets with high-binding affinity (nM or sub-nM range).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In cases of PDB-reported structure with a ligand other than staurosporine, wrapping predictions can be made but without the same confidence. For example, the active KIT structure complexed with ADP (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PKG">1PKG</a>) has a dehydron at the aligned position. Thus, all close KIT paralogues (CSF1R, FLT3, PDGFRA, PDGFRB with sequence identity >60%) will probably be targeted by <b>9</b>, as corroborated in the screening (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Furthermore, the LOK kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J7T">2J7T</a>) has a dehydron in such position and represents a hit. However, PAK6 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C30">2C30</a>) and SLK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J51">2J51</a>) have a well-wrapped hydrogen bond, and <b>9</b> still binds. Therefore, affinity predictions based on structures crystallized with ligands other than staurosporine are less reliable. However, the accuracy of our prediction is still high (46 out of 56 cases or ∼82%) if we further extend our structure-based analysis to include the set of 53 kinases with reported PDB structure that were recently screened (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (<a class="ref internalNav" href="#si1" aria-label="Table S1, Supporting Information">Table S1, Supporting Information</a>). Nevertheless, the higher selectivity of <b>9</b> is significant, showing high in vitro activity toward selected therapeutically relevant targets such as KIT (for treatment of gastrointestinal stromal tumors),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> PTK2 (involved in the metastasis of ovarian carcinoma),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> SRC (implicated in the metastatic/invasive phenotype),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> or EGFR (for treatment of nonsmall cell lung cancer).<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Thus, the wrapping modification of staurosporine may potentially be turned into a realistic clinical opportunity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected aligned backbones (ribbon representation) of EGFR (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue), PDPK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKY">1OKY</a>, red), and CDK2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1">1AQ1</a>, yellow) kinases complexed with compound <b>9</b>. The R776-Q791 dehydron in EGFR (green virtual bond joining α-carbons) maps into the well-wrapped backbone hydrogen bonds (gray virtual bonds joining α-carbons) K144−E160 in PDPK1 and K65-E81 in CDK2. The methyl group at the pyrrol N6-position (indicated by the green box) turns the ligand into a wrapper of the nonconserved dehydron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Wrapping Comparison of the 37 PDB-Reported Kinases in Complex with Staurosporine or with Ligands that Share the Same Chemotype at Position Aligned with EGFR Dehydron R776-Q791 (DH = Dehydron, HB = Well-Wrapped Hydrogen Bond)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">kinase</th><th align="center" valign="bottom">PDB</th><th align="center" valign="middle">wrappingclassification</th><th align="center" valign="middle">hit inscreening</th><th align="center" valign="middle">match predictionexperiment</th></tr></thead><tbody><tr valign="top"><td align="left">ABL1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HZ4">2HZ4</a></td><td align="left">DH</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CDK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1">1AQ1</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CHK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">DAPK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WVY">1WVY</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">EGFR (WT)</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a></td><td align="left">DH</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">EGFR (G719S)</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITQ">2ITQ</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">EGFR (L858R)</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITU">2ITU</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">FYN</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DQ7">2DQ7</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">GSK3β</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q3D">1Q3D</a></td><td align="left">DH</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td rowspan="2" align="left" valign="middle">IRAK4</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NRY">2NRY</a></td><td rowspan="2" align="left" valign="middle">HB</td><td rowspan="2" align="left" valign="middle">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC">2OIC</a></td><td align="left"> </td></tr><tr valign="top"><td rowspan="2" align="left" valign="middle">ITK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SM2">1SM2</a></td><td rowspan="2" align="left" valign="middle">HB</td><td rowspan="2" align="left" valign="middle">NO HIT</td><td rowspan="2" align="left" valign="middle">YES</td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SNU">1SNU</a></td></tr><tr valign="top"><td align="left">JAK3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ">1YVJ</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td rowspan="2" align="left" valign="middle">LCK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPD">1QPD</a></td><td align="left">DH</td><td rowspan="2" align="left" valign="middle">HIT</td><td rowspan="2" align="left" valign="middle">YES</td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPJ">1QPJ</a></td><td align="left">HB</td></tr><tr valign="top"><td align="left">MAP3K5</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CLQ">2CLQ</a></td><td align="left">DH</td><td align="left">NO HIT</td><td align="left">NO</td></tr><tr valign="top"><td align="left">MAP3K17</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GCD">2GCD</a></td><td align="left">DH</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td rowspan="2" align="left" valign="middle">MAPKAPK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NXK">1NXK</a></td><td rowspan="2" align="left" valign="middle">HB</td><td rowspan="2" align="left" valign="middle">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2PZY">2PZY</a></td><td align="left"> </td></tr><tr valign="top"><td align="left">MET</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0P">1R0P</a></td><td align="left">NO HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">MKNK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7">2HW7</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PAK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HY8">2HY8</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td rowspan="2" align="left" valign="middle">PDPK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKY">1OKY</a></td><td rowspan="2" align="left" valign="middle">HB</td><td rowspan="2" align="left" valign="middle">NO HIT</td><td rowspan="2" align="left" valign="middle">YES</td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKZ">1OKZ</a></td></tr><tr valign="top"><td align="left">PIK3CG</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z">1E8Z</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">PIM1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS">1YHS</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PIM2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IWI">2IWI</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PKAC-α</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC">1STC</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PRKCQ</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XJD">1XJD</a></td><td align="left">HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td rowspan="3" align="left" valign="middle">PTK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0J">2J0J</a></td><td align="left">HB</td><td rowspan="3" align="left" valign="middle">HIT</td><td rowspan="3" align="left" valign="middle">YES</td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0K">2J0K</a></td><td align="left">DH</td></tr><tr valign="top"><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0M">2J0M</a></td><td align="left">DH</td></tr><tr valign="top"><td align="left">SRC</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BYG">1BYG</a></td><td align="left">DH</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">STK16</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BUJ">2BUJ</a></td><td align="left">NO HB</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">SYK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC">1XBC</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">ZAP70</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U59">1U59</a></td><td align="left">HB</td><td align="left">NO HIT</td><td align="left">YES</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Compound <b>9</b> is predicted to bind only to kinases that have a dehydron at the aligned position, and the prediction is contrasted with its experimental screening.</p></div></div></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Affinity profile of compound <b>9</b>. High-throughput screening at 10 μM of <b>9</b> (red) over a battery of 220 human kinases displayed in a T7-bacteriophage-expressing library (Ambit Bioscience, San Diego, CA). The screening assay of staurosporine (blue) was used as control.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Hit values are reported as percentage bound kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cleaning Inhibitor <b>8</b></h3><div class="NLM_p">The irreversible kinase inhibitor <b>8</b> developed by Wyeth-Ayerst<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was launched as a major inhibitor of the EGFR kinase (IC<sub>50</sub> = 38.5 nM). Thus, its therapeutic interest to treat nonsmall cell lung cancer (NSCLC), colorectal neoplasia, and other EGFR-dependent solid tumors became apparent.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Phase I and II trials for such therapeutic applications are currently in progress and closed to new patients.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Recent high-throughput screening assays<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> revealed ∼50 targets (<i>K</i><sub>D</sub> < 3 μM) for <b>8</b>, making it a promiscuous drug with likely side effects. Other anti-NSCLC agents such as gefitinib or erlotinib share the same 4-anilinoquinoline chemotype,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> yet they are more specific EGFR inhibitors.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">The promiscuity of <b>8</b> can be traced to its intermolecular interactions with highly conserved residues within the EGFR kinase family. Compound <b>8</b> has a large solvent-accessible surface area (397 Å<sup>2</sup>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> that may increase the nonspecific van der Waals interactions with residues framing the ATP pocket. Moreover, its polar amide group that increases drug solubility may be involved in hydrogen bonds with backbone atoms of residues in the P-loop or in the nucleotide-binding loop. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, one important source of promiscuity of compound <b>8</b> is its terminal acryl group, which plays the role of electrophile in the irreversible Michael reaction with the nucleophile-conserved residues Cys or Ser in the nucleotide-binding loop of EGFR paralogues. The water-solublizing terminal <i>N</i>-dimethyl group may also accelerate such addition, serving as an intramolecular base catalyst for Michael reaction with the Cys or Ser residues due to the spatial proximity.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Another source of promiscuity of compound <b>8</b> is the intermolecular electrostatic interaction between its cyanide group and the gatekeeper residue (Thr or Met), typically conserved within the family (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural alignment of two targets of <b>8</b>: the EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a>, blue ribbon representation, atoms in balls and sticks) and the paralogue PAK1 kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHV">1YHV</a>, red ribbon representation, atoms licorice), complexed with the drug (licorice). Atoms are depicted following standard color convention (chlorine in green, fluorine in light green). The sources of promiscuity of compound <b>8</b> are the terminal acryl group (electrophile group in the Michael reaction) and its cyanide group (involved in intermolecular electrostatic interaction with a Thr or Met gatekeeper). EGFR has a poorly conserved D855-G857 dehydron (green virtual bond joining α-carbons) that may be targeted to achieve selectivity. PAK1 contains the same two promiscuity-fostering features, while it has a well-wrapped hydrogen bond aligned at such position (gray virtual bond joining α-carbons). Targeting such dehydron will ensure a discriminatory binding of EGFR without hitting PAK1, as experimentally corroborated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To validate whether such interactions are responsible for the promiscuity of compound <b>8</b>, we establish a correlation between the affinities of <b>8</b> for 53 paralogues of EGFR reported in the PDB (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>) and the extent of residue conservation at the Michael reaction site and at the gatekeeper position. To do so, we align each paralogue structure with the EGFR structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a>) and examine residues that align with C797 (Michael reactant) and T790 (gatekeeper) (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>).<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> A statistical model is built to assess such correlation (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>),<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> revealing that the affinity profile of <b>8</b> is indeed dictated by these two sources of promiscuity (<i>P</i>-value = 0.007). Thus, the terminal acryl group and the cyanide group of <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) are the “dirty” moieties responsible for its promiscuity.</div><div class="NLM_p">We thus remove the sources of promiscuity by introducing the two following chemical modifications (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>): (i) Replace the double bond (the Michael acceptor) in the acryl group with a single bond. (ii) Replace the cyanide group with a methyl to retain the chemotype while removing the electrostatic interaction with the gatekeeper.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. EGFR kinase structure (same representation as Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) complexed with compound <b>10</b> (licorice representation). To remove promiscuity, the acrylic double bond (Michael electrophile) and the gatekeeper-interacting cyanide group of <b>8</b> are replaced by a single bond and a methyl group, respectively. To selectively target EGFR, another methyl group is added to the terminal benzene ring as a wrapper of the least conserved D855-G857 dehydron (green virtual bond joining α-carbons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To promote selectivity, we further introduce a wrapping modification in the drug to target a nonconserved dehydron in the intended target. When EGFR is crystallized in the induced-fit conformation generated by an inhibitor (erlotinib) that shares <b>8</b>′s 4-anilinoquinoline chemotype (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a>), we now find only six dehydrons within the binding pocket (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>): G721-F723 and G721-G724 in the P-loop, M793-G796, P794-G796, and G796-V845 in the nucleotide-binding loop, and D855-G857 in the activation loop. From these six, dehydrons M793-G796 and D855-G857 are potentially more accessible to a wrapping modification of the drug. By examining these two dehydrons across the 53 EGFR-paralogues, we find that the least conserved and more accessible to a wrapping modification is dehydron D855-G857 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Only 12 paralogues retain this dehydron (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>): AURKA, CLK3, EGFR, EPHA3, ERBB2, FYN, LCK, PAK6, PAK7/PAK5, PIM2, SLK, and STK10, whereas dehydron M793-G796 is conserved in 17 kinases. Thus, we choose dehydron D855-G857 as the nonconserved selectivity feature to be targeted. To do so, we append a methyl group at position 3 of the terminal benzene ring of <b>8</b> that becomes a wrapper or protector of such feature (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The synthesis of the redesigned compound <b>10</b> follows a pathway that recapitulates the synthesis of the parental compound <b>8</b> (<a class="ref internalNav" href="#sec4" aria-label="Methods">Methods</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>10</b> buries a solvent-accessible surface area similar to <b>8</b>′s (393 Å<sup>2</sup> vs 397 Å<sup>2</sup>, respectively),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> showing a similar size and binding orientation and similar entropic penalty upon association. However, <b>10</b> not only lacks <b>8</b>′s sources of promiscuity but also introduces a wrapping modification to promote selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Wrapping Comparison for the Set of 53 Paralogue Kinases of EGFR with Reported PDB Structure<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">kinase</th><th align="center" valign="bottom">PDB</th><th align="center" valign="middle">wrappingclassification</th><th align="center" valign="middle">sterichindrance</th><th align="center" valign="middle">predictedaffinity</th><th align="center" valign="middle">experimentalaffinity</th><th align="center" valign="middle">match predictionexperiment</th></tr></thead><tbody><tr valign="top"><td align="left">ABL1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GQG">2GQG</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">ABL1 (T315I)</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V7A">2V7A</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">ABL1 (H396P)</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F4J">2F4J</a></td><td align="left">possibly induced</td><td align="left">NO</td><td align="left">possible HIT</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">AURKA</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQ4">1MQ4</a></td><td align="left">DH</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">BTK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K2P">1K2P</a></td><td align="left">possibly induced</td><td align="left">NO</td><td align="left">possible HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CAMK1D</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JC6">2JC6</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CAMK1G</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAM">2JAM</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CDK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1">1AQ1</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CDK5</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNG">1UNG</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CLK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CLK3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EU9">2EU9</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CNSK1G1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CMW">2CMW</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">CNSK1G2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C47">2C47</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">DAPK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A2A">2A2A</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">DAPK3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J90">2J90</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">EGFR</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">EPHA2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQB">1MQB</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">EPHA3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QO9">2QO9</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">NO HIT</td><td align="left">NO</td></tr><tr valign="top"><td align="left">ERBB2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVC">1OVC</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">FGFR1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AGW">1AGW</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">FGFR2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GJO">1GJO</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">FLT3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RJB">1RJB</a></td><td align="left">possibly induced</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">FYN</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DQ7">2DQ7</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">NO HIT</td><td align="left">NO</td></tr><tr valign="top"><td align="left">HCK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QCF">1QCF</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">INSR</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GAG">1GAG</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">JAK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B7A">2B7A</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">JNK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UKH">1UKH</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">JNK3</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN">1PMN</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">KIT</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PKG">1PKG</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">LCK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPC">1QPC</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">MAP3K5</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CLQ">2CLQ</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">MKNK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">NEK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAV">2JAV</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">P38-α</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DI9">1DI9</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">P38-γ</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CM8">1CM8</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PAK1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHV">1YHV</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PAK4</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CDZ">2CDZ</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PAK6</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C30">2C30</a></td><td align="left">DH</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PAK7/PAK5</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F57">2F57</a></td><td align="left">DH</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PDGFRB</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LWP">1LWP</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PIM1</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YXT">1YXT</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PIM2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IWI">2IWI</a></td><td align="left">DH</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PKAC-α</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GU8">2GU8</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">PTK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ETM">2ETM</a></td><td align="left">possibly induced</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">RPS6KA5</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VZO">1VZO</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">SLK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J51">2J51</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">SRC</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SRC">2SRC</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">STK10</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J7T">2J7T</a></td><td align="left">DH</td><td align="left">NO</td><td align="left">HIT</td><td align="left">HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">STK16</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BUJ">2BUJ</a></td><td align="left">possibly induced</td><td align="left">YES</td><td align="left">NO HIT</td><td align="left">not screened</td><td align="left"> </td></tr><tr valign="top"><td align="left">SYK</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBB">1XBB</a></td><td align="left">possibly induced</td><td align="left">NO</td><td align="left">possible HIT</td><td align="left">NO HIT</td><td align="left">NO</td></tr><tr valign="top"><td align="left">TIE2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVR">1FVR</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">TNK2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U46">1U46</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr><tr valign="top"><td align="left">VEGFR2</td><td align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P2H">2P2H</a></td><td align="left"> </td><td align="left"> </td><td align="left">NO HIT</td><td align="left">NO HIT</td><td align="left">YES</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Compound <b>10</b> is predicted to bind only to kinases with a dehydron or possibly induced dehydron in positions aligning with EGFR D855-G857 dehydron and with no steric hindrance. The prediction is contrasted with its experimental screening.</p></div></div></div><div class="NLM_p">Our structure-based affinity profile prediction for <b>10</b> is based on the conservation of the EGFR D855-G857 dehydron wrapped by <b>10</b> (<i>but not by</i><b>8</b>) and the existence of steric hindrances with the targets. In cases where there is a dehydron aligned with the EGFR D855-G857 dehydron, we predict steric hindrance only for those kinases that originally do not bind to <b>8</b> because they are likely to also clash sterically with <b>10</b>. This is expected because the binding to <b>8</b> implies that no steric hindrance occurs (the reciprocal does not hold). <i>We thus predict as “hits” only those kinases that introduce no steric hindrance and possess a dehydron in the position that aligns with EGFR D855-G857</i>. Only 8 hits are thus predicted (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>): CLK3, EGFR, EPHA3, ERBB2, FYN, LCK, SLK, and STK10. In cases where the residues aligning with EGFR D855-G857 are not engaged in a dehydron or in a well-wrapped hydrogen bond, we further examine whether such a dehydron can be induced upon ligand binding with a minimal structural adaptation. Four kinases (ABL1 (H396P), BTK, PTK2, and SYK, out of 6 cases: ABL1 (H396P), BTK, FLT3, PTK2, STK16, and SYK) can induce this dehydron upon drug binding with no steric hindrance, representing “possible” hits (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). <i>The experimentally obtained affinity profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) for compound</i><b>10</b><i>agrees very well with our predicted profile: it actually binds 6 (CLK3, EGFR, ERBB2, LCK, SLK, and STK10) out of the 8 hits inferred with certainty and two of the possible hits (BLK and PTK2).</i> It has only 3 false positives (EPHA3, FYN, and the other possible hit SYK) and not a single false negative (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) for the 50 cases where our prediction can be contrasted with experiment. These results show ∼94% of accuracy in the prediction.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Affinity profile of compound <b>10</b>. High-throughput screening at 10 μM of <b>10</b> (red) over a battery of 220 human kinases displayed in a T7-bacteriophage-expressing library (Ambit Bioscience, San Diego, CA). The screening assay of <b>8</b> (blue) was used as control.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Hit values are reported as percentage bound kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These results reveal that the wrapping redesign introduces a significant increase in the selectivity of the “dirty” inhibitor <b>8</b>. This is accomplished by first removing the drug features that promote promiscuity. Subsequently, we introduce a chemical modification that wraps a relatively unique dehydron in the intended kinase target. This rational redesign makes compound <b>10</b> more selective than the parental compound <b>8</b>: out of the 220 kinases experimentally screened, compound <b>10</b> binds strongly (sub-μM affinity or % of inhibition >10) to 5 kinases, whereas compound <b>8</b> binds to 19 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This work describes and validates a generic strategy in molecular design aimed at turning highly cross-reactive kinase inhibitors into significantly more selective drugs. To demonstrate the power of this approach, we selected the most challenging design problems, represented by the cleaning of the highly promiscuous ligands staurosporine and inhibitor <b>8</b>. The redesign of these compounds was guided by a selectivity filter: the pattern of packing defects, the so-called <i>dehydrons</i>, in the drug target that are not conserved across paralogues.<a onclick="showRef(event, 'ref25 ref30'); return false;" href="javascript:void(0);" class="ref ref25 ref30">(25, 30)</a> Thus, relatively unique dehydrons have been targeted by the redesigned compounds to further protect them from water attack upon association. In this way, we have significantly enhanced specificity in a highly controllable manner and even for the most promiscuous kinase inhibitors. Thus, a generic strategy may involve modifying the parental compound to turn it into a wrapper of poorly conserved dehydrons while removing potential sources of ligand promiscuity. This strategy may be successfully applied to other cross-reactive kinase inhibitors such as sunitinib and sorafenib, documented to entail a risk of side effects.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The structure-based affinity predictions for our wrapping prototypes were benchmarked against experimental screening,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> revealing over 90% accuracy. The reliability of wrapping predictions is contingent on the availability of target structures. The latter are typically reported for induced-fit conformations arising in drug/target complexes. Hence, the wrapping prediction requires that the PDB-reported complexes share the same ligand chemotype as the parental compound to ensure induced-fit similarity. Particular attention to induced-fit diversity is needed in drug design, especially in wrapping design, due to the conformational plasticity of kinases. Thus, wrapping design will undoubtedly benefit from an ever-increasing amount of reported data on structural adaptation of targets to diverse ligands as well as high-throughput screening of drug variants, enabling a dissection of specificity-promoting features. The efficacious solution to the problem of cleaning promiscuous drugs reported here highlights the value of the wrapping redesign as a paradigm shifter in the engineering of drug selectivity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Target Identification</h3><div class="NLM_p">To redesign staurosporine performing a comparative analysis of nonconserved selectivity features, we collected all 37 PDB-reported kinase structures complexed with staurosporine or with ligands that share the same indolo[2,3-<i>a</i>]pyrrolo[3,4-<i>c</i>]-carbazole chemotype.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> We only selected kinase structures in complex with such ligands, to avoid a less reliable identification of dehydrons, arising from different induced fits generated in presence of other drug/inhibitors.</div><div class="NLM_p">A similar structural analysis was performed for cleaning <b>8</b>. Because its primary intended target is the EGFR kinase, we adopted a PDB-reported structure of EGFR in complex with an inhibitor (erlotinib) that shares the same 4-anilinoquinoline chemotype (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A comparative analysis to identify potential sources of cross reactivity and nonconserved specificity-promoting features was performed for the 53 EGFR-paralogues with reported PDB structure that were recently screening using a battery of 119 T7-phage expressed kinases.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Moreover, the comparative wrapping analysis for staurosporine redesign was further extended to include this set of 53 paralogue kinases with reported PDB structure (<a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p last">For such comparative analysis, we have performed a structural alignment of all kinases in each set of targets. The alignment was performed using the DaliLite web-based program for pairwise structure comparison.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Structure conservation across targets within kinase families enables such alignment.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Statistical Analysis</h3><div class="NLM_p last">To verify that the sources of promiscuity of compound <b>8</b> are the extent of residue conservation at both the Michael reaction site and at the gatekeeper position, we performed a statistical analysis by building a logistic regression model.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Thus, we established a correlation between the affinities of <b>8</b> for the set of 53 EGFR-paralogues reported in PDB and the extent of residue conservation at such positions. The two “explanatory variables” are the types of residues aligning with C797 (Michael nucleophile) and T790 (gatekeeper). Thus, X<sub>1</sub> = 1, if the residue aligning with C797 is Cys or Ser (possible Michael nucleophiles), and X<sub>2</sub> = 1, if the residue aligning with T790 is Thr or Met (possible intermolecular electrostatic interaction with the cyanide group). The “responding variable” is the affinity of <b>8</b> toward the 53 EGFR-paralogues (<i>Y</i> = 1, if <i>K</i><sub>D</sub> < 3 μM).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The null hypothesis is the assumption that there is no correlation between the responding variable and the explanatory variables.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Dehydron Identification</h3><div class="NLM_p">Dehydrons may be readily identified from atomic coordinates of proteins with reported structure. Thus, we first identify all intramolecular backbone hydrogen bonds within the structure as bonds whose N−O distances are <3.5 Å and N−H−O angles are >110°. For each hydrogen bond identified, we then calculate its extent of wrapping, ρ, by quantifying the number of the side chain carbonaceous nonpolar groups contained within a “dehydration domain” around such bond. This domain is defined as two intersecting balls of fixed radius (∼thickness of three water layers) centered at the α-carbons of the residues paired by the hydrogen bond.</div><div class="NLM_p last">In structures of soluble proteins, at least two-thirds of the backbone hydrogen bonds are wrapped on average by ρ = 26.6 ± 7.5 nonpolar groups for a dehydration ball of radius 6.2 Å. Dehydrons lie in the tails of the distribution, i.e., their dehydration domains contain 19 or fewer nonpolar groups, so their ρ-values are below the mean (ρ = 26.6) minus one standard deviation (σ = 7.5).<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23-27)</a> Dehydrons were directly determined from a PDB file using the program YAPView (University of Chicago).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Redesigned Compounds</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (Pyrrol N6)-methyl-staurosporine (<b>9</b>)</h4><div class="NLM_p last">The synthesis of <b>9</b><a onclick="showRef(event, 'ref31 ref33 ref37'); return false;" href="javascript:void(0);" class="ref ref31 ref33 ref37">(31, 33, 37)</a> involves replacing the imide hydrogen atom in the pyrrol ring of staurosporine with a methyl group, as previously reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This modification was achieved by following the short pathway based on intramolecular Diels−Alder reaction of pyrano[4,3-<i>b</i>]indol-3-one, described in ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>, page 4399, replacing the first step by treatment of commercial 2-nitrocinnamaldehyde with 1,2-dimethyl hydrazine (for pyrrol N6 methylation) instead of hydrazine. The synthesis and spectroscopic characterization of <b>9</b> is provided as <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4-Dimethylamino-butanoic-acid-[4-(5-chloro-4-fluoro-3-methylphenylamino)-3-methyl-7-methoxy-quinoline-6-yl]-amide (<b>10</b>)</h4><div class="NLM_p">The synthesis of <b>10</b> entails several chemical modifications of the parental compound <b>8</b>:<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> replacing the double bond (Michael acceptor) in the acryl group with a single bond, replacing the cyanide group with a methyl, and appending a methyl group at position 3 of the terminal benzene ring. Thus, <b>10</b> was synthesized by following a pathway that recapitulates the synthesis of <b>8</b>, albeit with different reactants (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The synthesis and spectroscopic characterization of <b>10</b> is provided as <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0002.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Pathway of Compound <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Toluene, reflux. (b) Dowtherm, 256 °C. (c) POCl<sub>3</sub>, reflux. (d) Fe, NH<sub>4</sub>Cl, CH<sub>3</sub>OH, reflux. (e) <i>N,N</i>-diisopropylethylamine, THF, 0 °C. See <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> for details.</p></p></figure></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> High-Throughput Screening Assay</h4><div class="NLM_p last">A high-throughput screening assay of compounds <b>9</b> and <b>10</b> at 10 μM were conducted (Ambit Biosciences, San Diego, CA) against a bacteriophage library displaying 220 human kinases. The screening assays of both parental compounds (staurosporine and <b>8</b>, respectively) were used as control.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> A rough estimation of the binding constant (<i>K</i><sub>d</sub><sup>−1</sup>) for each assay was provided by the single-hit value in the primary screen at a single compound concentration. Kinase profiling was performed using a bacteriophage library displaying fused human kinases that may attach at the ATP site to a fixed-ligand matrix that may be competitively displaced from binding by the tested compound.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/jm800453a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Wrapping comparison, predicted affinity profile, and experimental screening of <b>9</b> against 56 PDB-reported kinase structures (Methods). Synthesis and spectroscopic characterization of compounds <b>9</b> and <b>10</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800453a/suppl_file/jm800453a-file002.pdf">jm800453a-file002.pdf (442.79 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800453a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ariel Fernández</span> - <span class="hlFld-Affiliation affiliation">Department of Bioengineering, Rice University, Houston, Texas 77005, Program in Applied Physics, Rice Quantum Institute, Rice University, Houston, Texas 77005</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e283908b848790a2908b8187cc878697"><span class="__cf_email__" data-cfemail="0e6f7c67686b7c4e7c676d6b206b6a7b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alejandro Crespo</span> - <span class="hlFld-Affiliation affiliation">Department of Bioengineering, Rice University, Houston, Texas 77005, Program in Applied Physics, Rice Quantum Institute, Rice University, Houston, Texas 77005</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xi Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Bioengineering, Rice University, Houston, Texas 77005, Program in Applied Physics, Rice Quantum Institute, Rice University, Houston, Texas 77005</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research is supported by NIH grant R01-GM072614 and by an unrestricted grant from Eli Lilly. We thank Drs. Harry Harlow and Chen Su (Eli Lilly) for their valuable input.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gibbs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliff, A.</span><span> </span><span class="NLM_article-title">Pharmaceutical research in molecular oncology</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">193</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=193-198&author=J.+Gibbsauthor=A.+Oliff&title=Pharmaceutical+research+in+molecular+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DJ.%26aulast%3DOliff%26aufirst%3DA.%26atitle%3DPharmaceutical%2520research%2520in%2520molecular%2520oncology%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Levitski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazit, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibition: an approach to drug development</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">267</span> <span class="NLM_fpage">1782</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1995&pages=1782-1788&author=A.+Levitskiauthor=A.+Gazit&title=Tyrosine+kinase+inhibition%3A+an+approach+to+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitski%26aufirst%3DA.%26aulast%3DGazit%26aufirst%3DA.%26atitle%3DTyrosine%2520kinase%2520inhibition%253A%2520an%2520approach%2520to%2520drug%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D267%26spage%3D1782%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Donato, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span> </span><span class="NLM_article-title">Clinical use of tyrosine kinase inhibitors: therapy for chronic myelogenous leukemia and other cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">2965</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=10955770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FmtVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2965-2966&author=N.+J.+Donatoauthor=M.+Talpaz&title=Clinical+use+of+tyrosine+kinase+inhibitors%3A+therapy+for+chronic+myelogenous+leukemia+and+other+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical use of tyrosine kinase inhibitors: therapy for chronic myelogenous leukemia and other cancers</span></div><div class="casAuthors">Donato N J; Talpaz M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2965-6</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThES6kKGIwE0NoizSOkG_FfW6udTcc2ebN-cr1FuDwp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FmtVWjug%253D%253D&md5=c9058bdfa50e3b511889a211c9eb50e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26atitle%3DClinical%2520use%2520of%2520tyrosine%2520kinase%2520inhibitors%253A%2520therapy%2520for%2520chronic%2520myelogenous%2520leukemia%2520and%2520other%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2965%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dancey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Issues and progress with protein kinase inhibitors for cancer treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">296</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrd1066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12669029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=296-313&author=J.+Danceyauthor=E.+A.+Sausville&title=Issues+and+progress+with+protein+kinase+inhibitors+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Issues and progress with protein kinase inhibitors for cancer treatment</span></div><div class="casAuthors">Dancey, Janet; Sausville, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">296-313</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Identification of the key roles of protein kinases in cancer has led to extensive efforts to develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 such agents are now in clin. trials.  Here, we consider the crucial issues in the development of kinase inhibitors for cancer, and discuss strategies to address the challenges raised by these issues in the light of preclin. and clin. experiences so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-u-kzpegLrVg90H21EOLACvtfcHk0ljNVS_kEhVNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWkt70%253D&md5=fb11803282bcc39b24fa238a6ab973c8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1066%26sid%3Dliteratum%253Aachs%26aulast%3DDancey%26aufirst%3DJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DIssues%2520and%2520progress%2520with%2520protein%2520kinase%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D296%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tibes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=357-384&author=R.+Tibesauthor=J.+Trentauthor=R.+Kurzrock&title=Tyrosine+kinase+inhibitors+and+the+dawn+of+molecular+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTibes%26aufirst%3DR.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTyrosine%2520kinase%2520inhibitors%2520and%2520the%2520dawn%2520of%2520molecular%2520cancer%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D357%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Molecular basis for specificity in the druggable kinome: sequence-based analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">23</span> <span class="NLM_fpage">563</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=563-572&author=J.+Chenauthor=X.+Zhangauthor=A.+Fern%C3%A1ndez&title=Molecular+basis+for+specificity+in+the+druggable+kinome%3A+sequence-based+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DMolecular%2520basis%2520for%2520specificity%2520in%2520the%2520druggable%2520kinome%253A%2520sequence-based%2520analysis%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D563%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">621</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0ljNVS_kEhVNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirrankar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. A.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">23</span> <span class="NLM_fpage">329</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+A.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgandauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zirrankarauthor=D.+A.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0liq6PjYHbQHOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BA.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgand%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZirrankar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BA.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Karaman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">127</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+K.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0liq6PjYHbQHOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BK.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapy: have floodgates opened</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=357-360&author=B.+J.+Druker&title=Molecularly+targeted+therapy%3A+have+floodgates+opened"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DMolecularly%2520targeted%2520therapy%253A%2520have%2520floodgates%2520opened%26jtitle%3DOncologist%26date%3D2004%26volume%3D9%26spage%3D357%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kerkelä, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">908</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkel%C3%A4author=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2eb3CIRhLWE0q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkel%25C3%25A4%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Force, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">332</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrc2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=17457301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=332-344&author=T.+Forceauthor=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Molecular+mechanisms+of+cardiotoxicity+of+tyrosine+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span></div><div class="casAuthors">Force, Thomas; Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-344</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer therapy has progressed remarkably in recent years.  In no area has this been more apparent than in the development of 'targeted therapies', particularly those using drugs that inhibit the activity of certain tyrosine kinases, activating mutations or amplifications of which are causal, or strongly contributory, to tumorigenesis.  However, some of these therapies have been assocd. with toxicity to the heart.  Here we summarize what is known about the cardiotoxicity of cancer drugs that target tyrosine kinases.  We focus on basic mechanisms through which interruption of specific signalling pathways leads to cardiomyocyte dysfunction and/or death, and contrast this with therapeutic responses in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyJIGdG9hv7Vg90H21EOLACvtfcHk0lgNvl6zPH0ggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D&md5=b574f420e2a09de9bae3aa2313e76c3e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2106%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520cardiotoxicity%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D332%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, A.</span><span> </span><span class="NLM_article-title">Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">493</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrd839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12120256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=493-502&author=R.+Capdevilleauthor=E.+Buchdungerauthor=J.+Zimmermannauthor=A.+Matter&title=Glivec+%28STI571%2C+imatinib%29%2C+a+rationally+developed%2C+targeted+anticancer+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</span></div><div class="casAuthors">Capdeville, Renaud; Buchdunger, Elisabeth; Zimmermann, Juerg; Matter, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-502</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the early 1980s, it became apparent that the work of pioneers such as Robert Weinberg, Mariano Barbacid and many others in identifying cancer-causing genes in humans was opening the door to a new era in anticancer research.  Motivated by this, and by dissatisfaction with the limited efficacy and tolerability of available anticancer modalities, a drug discovery program was initiated with the aim of rationally developing targeted anticancer therapies.  Here, we describe how this program led to the discovery and continuing development of Glivec (Gleevec in the United States), the first selective tyrosine-kinase inhibitor to be approved for the treatment of a cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeI0HV4de6ObVg90H21EOLACvtfcHk0lj05XbAowNIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKlurY%253D&md5=c8f6b7a66f74b64f0dedb5e641097acc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd839%26sid%3Dliteratum%253Aachs%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DMatter%26aufirst%3DA.%26atitle%3DGlivec%2520%2528STI571%252C%2520imatinib%2529%252C%2520a%2520rationally%2520developed%252C%2520targeted%2520anticancer%2520drug%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D493%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Atkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Sunitinib maleate</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">279</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=279-280&author=M.+Atkinsauthor=C.+A.+Jonesauthor=P.+Kirkpatrick&title=Sunitinib+maleate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DSunitinib%2520maleate%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D279%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Sorafenib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">453</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1517%2F14656566.7.4.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16503817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=453-461&author=B.+I.+Rini&title=Sorafenib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-461</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Sorafenib is a small mol. inhibitor of several kinases involved in tumor proliferation and tumor angiogenesis including Raf, VEGFR and platelet derived growth factor receptor.  In vivo Raf kinase inhibition has been obsd. in pharmacodynamic studies.  Sorafenib is one of several VEGF-targeting compds. with recently demonstrated substantial anti-tumor effects in metastatic renal cell carcinoma.  Delay in time to disease progression has been demonstrated in cytokine-refractory metastatic renal cell carcinoma, and further investigation is ongoing in a wide variety of tumor types.  Sorafenib is well tolerated, with common toxicities including rash, diarrhea, hand-foot skin reaction, fatigue and hypertension, when administered as the std. dose of 400 mg b.i.d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTbL_e_cFYVbVg90H21EOLACvtfcHk0lj05XbAowNIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVKgu78%253D&md5=07dddaf18041f4885a535485fa0dfa8a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.4.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.4.453%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DSorafenib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D453%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">McIntyre, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Er, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayes, M.</span><span> </span><span class="NLM_article-title">Dasatinib. Treatment of leukemia treatment of solid tumors Bcr-Abl and Src kinase inhibitor</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">291</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1358%2Fdof.2006.031.04.984426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=291-303&author=J.+A.+McIntyreauthor=J.+Erauthor=M.+Bayes&title=Dasatinib.+Treatment+of+leukemia+treatment+of+solid+tumors+Bcr-Abl+and+Src+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dasatinib: treatment of leukemia treatment of solid tumors Bcr-Abl and Src kinase inhibitor</span></div><div class="casAuthors">McIntyre, J. A.; Castaner, J.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-303</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Chronic myelogenous leukemia (CML) results from a single mutagenic event leading to acquisition of the Philadelphia chromosome abnormality and the BCR-ABL fusion gene.  Improved understanding of the mol. mechanisms of resistance in CML led to the discovery of the small-mol., dual Bcr-Abl and Src kinase inhibitor dasatinib (BMS-354825).  Dasatinib has 325-fold increased potency relative to imatinib and has demonstrated activity against a wide range of clin. relevant isoforms resistant to imatinib.  In a mouse model of imatinib-resistant, Bcr-Abl-dependent disease, dasatinib significantly prolonged survival.  It also demonstrated potent activity against cell lines overexpressing Src and Kit tyrosine kinases.  Preclin. studies have shown that dasatinib may also be active against solid malignancies, including breast and prostate carcinoma.  In phase I and II studies in patients with chronic-phase, accelerated-phase and myeloid blast crisis CML and Philadelphia chromosome-pos. acute lymphoblastic leukemia (Ph+ ALL) with hematol. resistance or intolerance to imatinib, durable responses were obtained, as well as cytogenetic responses in patients with a wide spectrum of Bcr-Abl mutations.  Regulatory submissions have been made in the U.S. and the E.G. for its use in CML and Ph+ ALL patients resistant or intolerant to prior therapy, and clin. studies are under way in several solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjM_YUwPgpdLVg90H21EOLACvtfcHk0lj05XbAowNIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsLY%253D&md5=7a7d5e10b4f946b93fb939f5667cdbe9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.984426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.984426%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntyre%26aufirst%3DJ.%2BA.%26aulast%3DEr%26aufirst%3DJ.%26aulast%3DBayes%26aufirst%3DM.%26atitle%3DDasatinib.%2520Treatment%2520of%2520leukemia%2520treatment%2520of%2520solid%2520tumors%2520Bcr-Abl%2520and%2520Src%2520kinase%2520inhibitor%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D291%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Leighl, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Res, D.</span><span> </span><span class="NLM_article-title">Erlotinib: Profile report</span> <span class="citation_source-journal">Drugs Ther. Perspect.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=1-2&author=N.+B.+Leighlauthor=D.+Res&title=Erlotinib%3A+Profile+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeighl%26aufirst%3DN.%2BB.%26aulast%3DRes%26aufirst%3DD.%26atitle%3DErlotinib%253A%2520Profile%2520report%26jtitle%3DDrugs%2520Ther.%2520Perspect.%26date%3D2006%26volume%3D22%26spage%3D1%26epage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cancellieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trisolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Clinical experience with gefitinib: An update</span> <span class="citation_source-journal">CRC Crit. Rev. Oncol. Hematol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">31</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1016%2Fj.critrevonc.2005.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16531062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD287lvFyguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=31-45&author=F.+Cappuzzoauthor=G.+Finocchiaroauthor=G.+Metroauthor=S.+Bartoliniauthor=E.+Magriniauthor=A.+Cancellieriauthor=R.+Trisoliniauthor=L.+Castaldiniauthor=G.+Talliniauthor=L.+Crino&title=Clinical+experience+with+gefitinib%3A+An+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience with gefitinib: an update</span></div><div class="casAuthors">Cappuzzo Federico; Finocchiaro Giovanna; Metro Giulio; Bartolini Stefania; Magrini Elisabetta; Cancellieri Alessandra; Trisolini Rocco; Castaldini Luciano; Tallini Giovanni; Crino Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-45</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Gefitinib is an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that blocks signal transduction pathways involved in cell proliferation.  This drug demonstrated impressive and durable responses in patients with heavily pretreated non-small cell lung cancer (NSCLC).  In two large phase II trials, responses were observed in 9-19% of unselected patients, along with symptom improvement and benefit in quality of life.  Biological mechanisms underlying TKI sensitivity have recently been discovered.  There is evidence that specific EGFR gene mutations and/or amplification confer a particularly sensitive phenotype, especially in individuals with tumors demonstrating activation of the anti-apoptotic protein Akt.  However, in all so far conducted clinical trials, no patient selection has been made, providing a logical explanation for the negative results observed in large phase III studies.  In the present review, we will summarize the results observed in clinical trials with gefitinib.  We will present results obtained in NSCLC and in other solid tumor, focusing on biological and clinical markers predicting drug sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnml1a0EdLEXthwrmtH4OBfW6udTcc2eadxZfvl36KLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287lvFyguw%253D%253D&md5=25114c49601a100d0a66b2e7b306bf37</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2005.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2005.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DBartolini%26aufirst%3DS.%26aulast%3DMagrini%26aufirst%3DE.%26aulast%3DCancellieri%26aufirst%3DA.%26aulast%3DTrisolini%26aufirst%3DR.%26aulast%3DCastaldini%26aufirst%3DL.%26aulast%3DTallini%26aufirst%3DG.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DClinical%2520experience%2520with%2520gefitinib%253A%2520An%2520update%26jtitle%3DCRC%2520Crit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2006%26volume%3D58%26spage%3D31%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozturk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shavrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangala, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelovani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span> </span><span class="NLM_article-title">An anticancer C-kit kinase inhibitor is re-engineered to make it more active and less cardiotoxic</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">4044</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=4044-4054&author=A.+Fern%C3%A1ndezauthor=A.+Sanguinoauthor=Z.+Pengauthor=E.+Ozturkauthor=J.+Chenauthor=A.+Crespoauthor=S.+Wulfauthor=A.+Shavrinauthor=C.+Qinauthor=J.+Maauthor=J.+Trentauthor=Y.+Linauthor=H.+Hanauthor=L.+S.+Mangalaauthor=J.+A.+Banksonauthor=J.+Gelovaniauthor=A.+Samarelauthor=W.+Bornmannauthor=A.+K.+Soodauthor=G.+L%C3%B3pez-Berestein&title=An+anticancer+C-kit+kinase+inhibitor+is+re-engineered+to+make+it+more+active+and+less+cardiotoxic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DSanguino%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DOzturk%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DShavrin%26aufirst%3DA.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DMangala%26aufirst%3DL.%2BS.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DGelovani%26aufirst%3DJ.%26aulast%3DSamarel%26aufirst%3DA.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26atitle%3DAn%2520anticancer%2520C-kit%2520kinase%2520inhibitor%2520is%2520re-engineered%2520to%2520make%2520it%2520more%2520active%2520and%2520less%2520cardiotoxic%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D4044%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Demetri, G.</span><span> </span><span class="NLM_article-title">Structural reengineering of imatinib to decrease cardiac risk in cancer therapy</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">3650</span> <span class="NLM_lpage">3653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3650-3653&author=G.+Demetri&title=Structural+reengineering+of+imatinib+to+decrease+cardiac+risk+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%26atitle%3DStructural%2520reengineering%2520of%2520imatinib%2520to%2520decrease%2520cardiac%2520risk%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3650%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Crunkhorn, S.</span><span> </span><span class="NLM_article-title">Anticancer drugs: Redesigning kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">120</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=120-121&author=S.+Crunkhorn&title=Anticancer+drugs%3A+Redesigning+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrunkhorn%26aufirst%3DS.%26atitle%3DAnticancer%2520drugs%253A%2520Redesigning%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D120%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Kinase packing defects as drug targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">917</span> <span class="NLM_lpage">923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=917-923&author=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Kinase+packing+defects+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DKinase%2520packing%2520defects%2520as%2520drug%2520targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D917%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheraga, H. A.</span><span> </span><span class="NLM_article-title">Insufficiently dehydrated hydrogen bonds as determinants of protein interactions</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">100</span> <span class="NLM_fpage">113</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=113-118&author=A.+Fern%C3%A1ndezauthor=H.+A.+Scheraga&title=Insufficiently+dehydrated+hydrogen+bonds+as+determinants+of+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScheraga%26aufirst%3DH.%2BA.%26atitle%3DInsufficiently%2520dehydrated%2520hydrogen%2520bonds%2520as%2520determinants%2520of%2520protein%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. R.</span><span> </span><span class="NLM_article-title">Adherence of packing defects in soluble proteins</span> <span class="citation_source-journal">Phys. Rev. Lett.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">91</span><span class="NLM_elocation-id">018102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&author=A.+Fern%C3%A1ndezauthor=L.+R.+Scott&title=Adherence+of+packing+defects+in+soluble+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DL.%2BR.%26atitle%3DAdherence%2520of%2520packing%2520defects%2520in%2520soluble%2520proteins%26jtitle%3DPhys.%2520Rev.%2520Lett.%26date%3D2003%26volume%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. R.</span><span> </span><span class="NLM_article-title">Dehydron: A structurally encoded signal for protein interaction</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">1914</span> <span class="NLM_lpage">1928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=1914-1928&author=A.+Fern%C3%A1ndezauthor=L.+R.+Scott&title=Dehydron%3A+A+structurally+encoded+signal+for+protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DL.%2BR.%26atitle%3DDehydron%253A%2520A%2520structurally%2520encoded%2520signal%2520for%2520protein%2520interaction%26jtitle%3DBiophys.%2520J.%26date%3D2003%26volume%3D85%26spage%3D1914%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Keeping dry and crossing membranes</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">1081</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=1081-1084&author=A.+Fern%C3%A1ndez&title=Keeping+dry+and+crossing+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DKeeping%2520dry%2520and%2520crossing%2520membranes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2004%26volume%3D22%26spage%3D1081%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pietrosemoli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Dehydration propensity of order−disorder intermediate regions in soluble proteins</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">3519</span> <span class="NLM_lpage">3526</span></span><div class="citationLinks">[<a href="/doi/10.1021/pr070208k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVWitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3519-3526&author=N.+Pietrosemoliauthor=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Dehydration+propensity+of+order%E2%88%92disorder+intermediate+regions+in+soluble+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dehydration Propensity of Order-Disorder Intermediate Regions in Soluble Proteins</span></div><div class="casAuthors">Pietrosemoli, Natalia; Crespo, Alejandro; Fernandez, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3519-3526</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. folded proteins maintain their structural integrity by properly shielding most backbone amides and carbonyls from full hydration.  This structure "wrapping" entails a proper packing of the intramol. hydrogen bonds.  Thus, a poorly wrapped hydrogen bond constitutes an identifiable packing defect.  Such defects are promoters of protein assocns. since they favor the removal of hydrating mols.  In this work we show that large clusters of packing defects generate the most significant dehydration hot spots on the protein surface, inducing a strong dielec. modulation that is reflected by a local quenching of the dielec. permittivity.  The PDB-reported proteins with the largest clusters of packing defects are found to be three cancer-related transcription factors, four highly interactive proteins related to cell signaling and cytoskeleton, and a cellular prion protein.  A large concn. of packing defects in a sol. protein constitutes a structural singularity that is intermediate between order and disorder.  The functional implications of this singularity are investigated to delineate diverse interrelated roles.  The presence of these large clusters signals a structural vulnerability, a pronounced dehydration propensity, and a strong electrostatic enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogFSuxX6w_v7Vg90H21EOLACvtfcHk0ljGuj80WuLlhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVWitLw%253D&md5=95ecc607f01ab42a7cc72802d10cf08b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fpr070208k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr070208k%26sid%3Dliteratum%253Aachs%26aulast%3DPietrosemoli%26aufirst%3DN.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DDehydration%2520propensity%2520of%2520order%25E2%2588%2592disorder%2520intermediate%2520regions%2520in%2520soluble%2520proteins%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2007%26volume%3D6%26spage%3D3519%26epage%3D3526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Incomplete protein packing as a selectivity filter in drug design</span> <span class="citation_source-journal">Structure</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1829</span> <span class="NLM_lpage">1836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1829-1836&author=A.+Fern%C3%A1ndez&title=Incomplete+protein+packing+as+a+selectivity+filter+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DIncomplete%2520protein%2520packing%2520as%2520a%2520selectivity%2520filter%2520in%2520drug%2520design%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26spage%3D1829%26epage%3D1836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozturk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span> </span><span class="NLM_article-title">Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">4028</span> <span class="NLM_lpage">4033</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4028-4033&author=A.+Fern%C3%A1ndezauthor=A.+Sanguinoauthor=Z.+Pengauthor=A.+Crespoauthor=E.+Ozturkauthor=X.+Zhangauthor=S.+Wangauthor=W.+Bornmannauthor=G.+L%C3%B3pez-Berestein&title=Rational+drug+redesign+to+overcome+drug+resistance+in+cancer+therapy%3A+imatinib+moving+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DSanguino%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DOzturk%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26atitle%3DRational%2520drug%2520redesign%2520to%2520overcome%2520drug%2520resistance%2520in%2520cancer%2520therapy%253A%2520imatinib%2520moving%2520target%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4028%26epage%3D4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, R. S.</span><span> </span><span class="NLM_article-title">Molecular dimension explored in evolution to promote proteomic complexity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">101</span> <span class="NLM_fpage">13460</span> <span class="NLM_lpage">13465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=13460-13465&author=A.+Fern%C3%A1ndezauthor=R.+S.+Berry&title=Molecular+dimension+explored+in+evolution+to+promote+proteomic+complexity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520dimension%2520explored%2520in%2520evolution%2520to%2520promote%2520proteomic%2520complexity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D13460%26epage%3D13465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Link, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghavan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danishefsky, S. J.</span><span> </span><span class="NLM_article-title">First total synthesis of staurosporine and ent-staurosporine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">552</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00106a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=552-553&author=J.+T.+Linkauthor=S.+Raghavanauthor=S.+J.+Danishefsky&title=First+total+synthesis+of+staurosporine+and+ent-staurosporine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja00106a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00106a072%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BT.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DFirst%2520total%2520synthesis%2520of%2520staurosporine%2520and%2520ent-staurosporine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D552%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">49</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.+Wangauthor=L.+M.+Greenbergerauthor=H.+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddipati, S.</span><span> </span><span class="NLM_article-title">The a priori inference of cross reactivity for drug-targeted kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">3092</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060163j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3092-3100&author=A.+Fern%C3%A1ndezauthor=S.+Maddipati&title=The+a+priori+inference+of+cross+reactivity+for+drug-targeted+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060163j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060163j%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DMaddipati%26aufirst%3DS.%26atitle%3DThe%2520a%2520priori%2520inference%2520of%2520cross%2520reactivity%2520for%2520drug-targeted%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3092%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhoud, B. S.</span><span> </span><span class="NLM_article-title">Structural basis for Chk1 inhibition by UCN-01</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">277</span> <span class="NLM_fpage">46609</span> <span class="NLM_lpage">46615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1074%2Fjbc.M201233200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12244092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46609-46615&author=B.+Zhaoauthor=M.+J.+Bowerauthor=P.+J.+McDevittauthor=H.+Zhaoauthor=S.+T.+Davisauthor=K.+O.+Johansonauthor=S.+M.+Greenauthor=N.+O.+Conchaauthor=B.+S.+Zhoud&title=Structural+basis+for+Chk1+inhibition+by+UCN-01"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Chk1 Inhibition by UCN-01</span></div><div class="casAuthors">Zhao, Baoguang; Bower, Michael J.; McDevitt, Patrick J.; Zhao, Huizhen; Davis, Stephen T.; Johanson, Kyung O.; Green, Susan M.; Concha, Nestor O.; Zhou, Bin-Bing S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46609-46615</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chk1 is a serine-threonine kinase that plays an important role in the DNA damage response, including G2/M cell cycle control.  UCN-01 (7-hydroxystaurosporine), currently in clin. trials, has recently been shown to be a potent Chk1 inhibitor that abrogates the G2/M checkpoint induced by DNA-damaging agents.  To understand the structural basis of Chk1 inhibition by UCN-01, we detd. the crystal structure of the Chk1 kinase domain in complex with UCN-01.  Chk1 structures with staurosporine and its analog SB-218078 were also detd.  All three compds. bind in the ATP-binding pocket of Chk1, producing only slight changes in the protein conformation.  Selectivity of UCN-01 toward Chk1 over cyclin-dependent kinases can be explained by the presence of a hydroxyl group in the lactam moiety interacting with the ATP-binding pocket.  Hydrophobic interactions and hydrogen-bonding interactions were obsd. in the structures between UCN-01 and the Chk1 kinase domain.  The high structural complementarity of these interactions is consistent with the potency and selectivity of UCN-01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6biZWQjRI0rVg90H21EOLACvtfcHk0ljAJYTNiDiIRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D&md5=bc5ab22df94aa4f458f752a808d49a92</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201233200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201233200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DP.%2BJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DJohanson%26aufirst%3DK.%2BO.%26aulast%3DGreen%26aufirst%3DS.%2BM.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DZhoud%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520basis%2520for%2520Chk1%2520inhibition%2520by%2520UCN-01%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46609%26epage%3D46615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Dieckmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienaber, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajashankar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span> </span><span class="NLM_article-title">Novel mode of Gleevec binding is revealed by the structure of Spleen Tyrosine Kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">279</span> <span class="NLM_fpage">55827</span> <span class="NLM_lpage">55832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+M%C3%BCller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=Novel+mode+of+Gleevec+binding+is+revealed+by+the+structure+of+Spleen+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DM%25C3%25BCller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DNovel%2520mode%2520of%2520Gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520Spleen%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spehner, J. C.</span><span> </span><span class="NLM_article-title">Reduced surface: An efficient way to compute molecular surfaces</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">305</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1002%2F%28SICI%291097-0282%28199603%2938%3A3%3C305%3A%3AAID-BIP4%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=8906967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADyaK28XhtlOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=305-320&author=M.+F.+Sannerauthor=A.+J.+Olsonauthor=J.+C.+Spehner&title=Reduced+surface%3A+An+efficient+way+to+compute+molecular+surfaces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced surface: an efficient way to compute molecular surfaces</span></div><div class="casAuthors">Sanner, Michel F.; Olson, Arthur J.; Spehner, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-20</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Because of their wide use in mol. modeling, methods to compute mol. surfaces have received a lot of interest in recent years.  However, most of the proposed algorithms compute the anal. representation of only the solvent-accessible surface.  There are a few programs that compute the anal. representation of the solvent-excluded surface, but they often have problems handling singular cases of self-intersecting surfaces and tend to fail on large mols. (more than 10,000 atoms).  We describe here a program called MSMS, which is shown to be fast and reliable in computing mol. surfaces.  It relies on the use of the reduced surface that is briefly defined here and from which the solvent-accessible and solvent-excluded surfaces are computed.  The four algorithms composing MSMS are described and their complexity is analyzed.  Special attention is given to the handling of self-intersecting parts of the solvent-excluded surface singularities.  The program has been compared with Connolly's program PQMS [M. L. Connolly (1993) Journal of mol. Graphics, Vol. 11, pp 139-141] on a set of 709 mols. taken from the Brookhaven Data Base.  MSMS was able to compute topol. correct surfaces for each mol. in the set.  Moreover, the actual time spent to compute surfaces is in agreement with the theor. complexity of the program, which is shown to be O[n log(n)] for n atoms.  On a Hewlett-Packard 9000/735 workstation, MSMS takes 0.73 s to produce a triangulated solvent-excluded surface for crambin (1crn, 46 residues, 327 atoms, 4772 triangles), 4.6 s for thermolysin (3tln, 316 residues, 2437 atoms, 26462 triangles), and 104.53 s for glutamine synthetase (2gls, 5676 residues, 43632 atoms, 476665 triangles).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHh9yYKrEtzbVg90H21EOLACvtfcHk0ljAJYTNiDiIRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtlOisro%253D&md5=5d219165a50709300cebc0853afb1dd3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199603%2938%3A3%3C305%3A%3AAID-BIP4%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199603%252938%253A3%253C305%253A%253AAID-BIP4%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DSpehner%26aufirst%3DJ.%2BC.%26atitle%3DReduced%2520surface%253A%2520An%2520efficient%2520way%2520to%2520compute%2520molecular%2520surfaces%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D305%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Knölker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span> </span><span class="NLM_article-title">Isolation and synthesis of biologically active carbazole alkaloids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">102</span> <span class="NLM_fpage">4303</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020059j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4303-4427&author=H.+J.+Kn%C3%B6lkerauthor=K.+R.+Reddy&title=Isolation+and+synthesis+of+biologically+active+carbazole+alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr020059j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020059j%26sid%3Dliteratum%253Aachs%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26atitle%3DIsolation%2520and%2520synthesis%2520of%2520biologically%2520active%2520carbazole%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4303%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span> <span class="citation_source-journal">N. Engl. J. Med</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">347</span> <span class="NLM_fpage">472</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1056%2FNEJMoa020461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12181401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=472-480&author=G.+D.+Demetriauthor=M.+von+Mehrenauthor=C.+D.+Blankeauthor=A.+D.+Van+den+Abbeeleauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=M.+C.+Heinrichauthor=D.+A.+Tuvesonauthor=S.+Singerauthor=M.+Janicekauthor=J.+A.+Fletcherauthor=S.+G.+Silvermanauthor=S.+L.+Silbermanauthor=R.+Capdevilleauthor=B.+Kieseauthor=B.+Pengauthor=S.+Dimitrijevicauthor=B.+J.+Drukerauthor=C.+Corlessauthor=C.+D.+M.+Fletcherauthor=H.+Joensuu&title=Efficacy+and+safety+of+imatinib+mesylate+in+advanced+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span></div><div class="casAuthors">Demetri, George D.; von Mehren, Margaret; Blanke, Charles D.; Van den Abbeele, Annick D.; Eisenberg, Burton; Roberts, Peter J.; Heinrich, Michael C.; Tuveson, David A.; Singer, Samuel; Janicek, Milos; Fletcher, Jonathan A.; Silverman, Stuart G.; Silberman, Sandra L.; Capdeville, Renaud; Kiese, Beate; Peng, Bin; Dimitrijevic, Sasa; Druker, Brian J.; Corless, Christopher; Fletcher, Christopher D. M.; Joensuu, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Constitutive activation of KIT receptor tyrosine kinase is crit. in the pathogenesis of gastrointestinal stromal tumors.  Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclin. models and preliminary clin. studies to have activity against such tumors.  We conducted an open-label, randomized, multicenter trial to evaluate the activity of imatinib in patients with advanced gastrointestinal stromal tumor.  We assessed antitumor response and the safety and tolerability of the drug.  Pharmacokinetics were assessed in a subgroup of patients.  A total of 147 patients were randomly assigned to receive 400 mg or 600 mg of imatinib daily.  Overall, 79 patients (53.7 percent) had a partial response, 41 patients (27.9 percent) had stable disease, and for tech. reasons, response could not be evaluated in 7 patients (4.8 percent).  No patient had a complete response to the treatment.  The median duration of response had not been reached after a median follow-up of 24 wk after the onset of response.  Early resistance to imatinib was noted in 20 patients (13.6 percent).  Therapy was well tolerated, although mild-to-moderate edema, diarrhea, and fatigue were common.  Gastrointestinal or intraabdominal hemorrhage occurred in approx. 5 percent of patients.  There were no significant differences in toxic effects or response between the two doses.  Imatinib was well absorbed, with pharmacokinetics similar to those reported in patients with chronic myeloid leukemia.  Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor.  Inhibition of the KIT signal-transduction pathway is a promising treatment for advanced gastrointestinal stromal tumors, which resist conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVE0HpuuKXXrVg90H21EOLACvtfcHk0liA3fbgrYkLPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D&md5=95c9ea076dd2b0e053ae2061cb3f5d24</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020461%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DJanicek%26aufirst%3DM.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DSilverman%26aufirst%3DS.%2BG.%26aulast%3DSilberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DCorless%26aufirst%3DC.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%2BM.%26aulast%3DJoensuu%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520imatinib%2520mesylate%2520in%2520advanced%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med%26date%3D2002%26volume%3D347%26spage%3D472%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Halder, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Therapeutic efficacy of a novel FAK inhibitor TAE226 in ovarian carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">10976</span> <span class="NLM_lpage">10983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10976-10983&author=J.+B.+Halderauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=W.+A.+Spannuthauthor=A.+M.+Nickauthor=T.+Hondaauthor=A.+A.+Kamatauthor=L.+Hanauthor=T.+J.+Kimauthor=C.+Luauthor=A.+M.+Tariauthor=W.+Bornmannauthor=A.+Fern%C3%A1ndezauthor=G.+L%C3%B3pez-Beresteinauthor=A.+K.+Sood&title=Therapeutic+efficacy+of+a+novel+FAK+inhibitor+TAE226+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%2BB.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DNick%26aufirst%3DA.%2BM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DTherapeutic%2520efficacy%2520of%2520a%2520novel%2520FAK%2520inhibitor%2520TAE226%2520in%2520ovarian%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10976%26epage%3D10983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">FRNK blocks v-Src stimulated invasion and experimental metastasis without effects on cell motility or growth</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">6289</span> <span class="NLM_lpage">6302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6289-6302&author=C.+R.+Hauckauthor=D.+A.+Hsiaauthor=X.+S.+Puenteauthor=D.+A.+Chereshauthor=D.+D.+Schlaepfer&title=FRNK+blocks+v-Src+stimulated+invasion+and+experimental+metastasis+without+effects+on+cell+motility+or+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DFRNK%2520blocks%2520v-Src%2520stimulated%2520invasion%2520and%2520experimental%2520metastasis%2520without%2520effects%2520on%2520cell%2520motility%2520or%2520growth%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D6289%26epage%3D6302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">1024</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0ljVvlIq5C80DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1024%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorusi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">2252</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boniauthor=P.+Martinsauthor=S.+E.+Quinnauthor=C.+Zacharchukauthor=P.+Amorusiauthor=A.+A.+Adjeiauthor=E.+K.+Rowinsky&title=Phase+I+study+of+EKB-569%2C+an+irreversible+inhibitor+of+the+epidermal+growth+factor+receptor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean ± std. deviation terminal half-life was 21.7 ± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0ljVvlIq5C80DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26aulast%3DMartins%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DS.%2BE.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DAmorusi%26aufirst%3DP.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520study%2520of%2520EKB-569%252C%2520an%2520irreversible%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Holm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span> </span><span class="NLM_article-title">DaliLite workbench for protein structure comparison</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">566</span> <span class="NLM_lpage">567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=566-567&author=L.+Holmauthor=J.+Park&title=DaliLite+workbench+for+protein+structure+comparison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolm%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DJ.%26atitle%3DDaliLite%2520workbench%2520for%2520protein%2520structure%2520comparison%26jtitle%3DBioinformatics%26date%3D2000%26volume%3D16%26spage%3D566%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>DaliLite Pairwise Comparison of Protein Structures. <a href="http://www.ebi.ac.uk/DaliLite/" class="extLink">http://www.ebi.ac.uk/DaliLite/</a> (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DaliLite+Pairwise+Comparison+of+Protein+Structures.+http%3A%2F%2Fwww.ebi.ac.uk%2FDaliLite%2F+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDaliLite%2520Pairwise%2520Comparison%2520of%2520Protein%2520Structures" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Agresti, A.</span> <span class="citation_source-book">Logistic Regression. An Introduction to Categorical Data Analysis.</span><span class="NLM_publisher-name">Wiley Interscience</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1996</span>; pp  <span class="NLM_fpage">103</span>− <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=103-144&author=A.+Agresti&title=Logistic+Regression.+An+Introduction+to+Categorical+Data+Analysis."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAgresti%26aufirst%3DA.%26btitle%3DLogistic%2520Regression.%2520An%2520Introduction%2520to%2520Categorical%2520Data%2520Analysis.%26pub%3DWiley%2520Interscience%26date%3D1996%26spage%3D103%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="ref46_1"><span>Logistic Regression. <a href="http://statpages.org/logistic.html" class="extLink">http://statpages.org/logistic.html</a> (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Logistic+Regression.+http%3A%2F%2Fstatpages.org%2Flogistic.html+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref46_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DLogistic%2520Regression" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="ref47_1"><span>Protein Library. <a href="http://protlib.uchicago.edu/dloads.html" class="extLink">http://protlib.uchicago.edu/dloads.html</a>  (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Library.+http%3A%2F%2Fprotlib.uchicago.edu%2Fdloads.html+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref47_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Library" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['ref46_1'],'ref47':['ref47_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X. H.  Ma</span>, <span class="hlFld-ContribAuthor ">R.  Wang</span>, <span class="hlFld-ContribAuthor ">C. Y.  Tan</span>, <span class="hlFld-ContribAuthor ">Y. Y.  Jiang</span>, <span class="hlFld-ContribAuthor ">T.  Lu</span>, <span class="hlFld-ContribAuthor ">H. B.  Rao</span>, <span class="hlFld-ContribAuthor ">X. Y.  Li</span>, <span class="hlFld-ContribAuthor ">M. L.  Go</span>, <span class="hlFld-ContribAuthor ">B. C.  Low</span>, and <span class="hlFld-ContribAuthor ">Y. Z.  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Virtual Screening of Selective Multitarget Kinase Inhibitors by Combinatorial Support Vector Machines. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2010,</strong> <em>7 </em>
                                    (5)
                                     , 1545-1560. <a href="https://doi.org/10.1021/mp100179t" title="DOI URL">https://doi.org/10.1021/mp100179t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp100179t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp100179t%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DVirtual%252BScreening%252Bof%252BSelective%252BMultitarget%252BKinase%252BInhibitors%252Bby%252BCombinatorial%252BSupport%252BVector%252BMachines%26aulast%3DMa%26aufirst%3DX.%2BH.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D2010%26date%3D31%252008%25202009%26date%3D16%252008%25202010%26date%3D7%252008%25202010%26date%3D26082010%26date%3D04102010%26date%3D16082010%26volume%3D7%26issue%3D5%26spage%3D1545%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthäus  Getlik</span>, <span class="hlFld-ContribAuthor ">Christian  Grütter</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Simard</span>, <span class="hlFld-ContribAuthor ">Sabine  Klüter</span>, <span class="hlFld-ContribAuthor ">Matthias  Rabiller</span>, <span class="hlFld-ContribAuthor ">Haridas B.  Rode</span>, <span class="hlFld-ContribAuthor ">Armin  Robubi</span> and <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (13)
                                     , 3915-3926. <a href="https://doi.org/10.1021/jm9002928" title="DOI URL">https://doi.org/10.1021/jm9002928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9002928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9002928%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHybrid%252BCompound%252BDesign%252BTo%252BOvercome%252Bthe%252BGatekeeper%252BT338M%252BMutation%252Bin%252BcSrc%26aulast%3DGetlik%26aufirst%3DMatth%25C3%25A4us%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D8%252003%25202009%26date%3D22052009%26date%3D09072009%26volume%3D52%26issue%3D13%26spage%3D3915%26epage%3D3926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shannon N.  Westin</span>, <span class="hlFld-ContribAuthor ">Anil K.  Sood</span>, <span class="hlFld-ContribAuthor ">Robert L.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapy and Molecular Genetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 470-492.e10. <a href="https://doi.org/10.1016/B978-0-323-40067-1.00018-8" title="DOI URL">https://doi.org/10.1016/B978-0-323-40067-1.00018-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-40067-1.00018-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-40067-1.00018-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapy%252Band%252BMolecular%252BGenetics%26aulast%3DWestin%26aufirst%3DShannon%2BN.%26date%3D2018%26spage%3D470%26epage%3D492.e10%26pub%3DElsevier%26atitle%3DClinical%252BGynecologic%252BOncology%26date%3D2018%26volume%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjit  Ganguly</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Hong</span>, <span class="hlFld-ContribAuthor ">Luke G.F.  Smith</span>, <span class="hlFld-ContribAuthor ">Harley I.  Kornblum</span>, <span class="hlFld-ContribAuthor ">Ichiro  Nakano</span>. </span><span class="cited-content_cbyCitation_article-title">Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2014,</strong> <em>13 </em>
                                    (6)
                                     , 1393-1398. <a href="https://doi.org/10.1158/1535-7163.MCT-13-0764" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-13-0764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-13-0764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-13-0764%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMaternal%252BEmbryonic%252BLeucine%252BZipper%252BKinase%25253A%252BKey%252BKinase%252Bfor%252BStem%252BCell%252BPhenotype%252Bin%252BGlioma%252Band%252BOther%252BCancers%26aulast%3DGanguly%26aufirst%3DRanjit%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D1393%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Nilesh  Zaware</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Bryan C.  Disch</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Anja  Bastian</span>, <span class="hlFld-ContribAuthor ">Michael A.  Ihnat</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (7)
                                     , 1857-1864. <a href="https://doi.org/10.1016/j.bmc.2013.01.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.01.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.01.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252B5-chloro-N4-substituted%252Bphenyl-9H-pyrimido%25255B4%25252C5-b%25255Dindole-2%25252C4-diamines%252Bas%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor-2%252Binhibitors%252Band%252Bantiangiogenic%252Bagents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2013%26volume%3D21%26issue%3D7%26spage%3D1857%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suyoun  Chung</span>, <span class="hlFld-ContribAuthor ">Hanae  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takashi  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Naofumi  Takamatsu</span>, <span class="hlFld-ContribAuthor ">Ayako  Tatsuguchi</span>, <span class="hlFld-ContribAuthor ">Koji  Ueda</span>, <span class="hlFld-ContribAuthor ">Kyoko  Kijima</span>, <span class="hlFld-ContribAuthor ">Yusuke  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yo  Matsuo</span>. </span><span class="cited-content_cbyCitation_article-title">Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2012,</strong> <em>3 </em>
                                    (12)
                                     , 1629-1640. <a href="https://doi.org/10.18632/oncotarget.790" title="DOI URL">https://doi.org/10.18632/oncotarget.790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.790%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDevelopment%252Bof%252Ban%252Borally-administrative%252BMELK-targeting%252Binhibitor%252Bthat%252Bsuppresses%252Bthe%252Bgrowth%252Bof%252Bvarious%252Btypes%252Bof%252Bhuman%252Bcancer%26aulast%3DChung%26aufirst%3DSuyoun%26date%3D2012%26date%3D2012%26volume%3D3%26issue%3D12%26spage%3D1629%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shannon N.  Westin</span>, <span class="hlFld-ContribAuthor ">Anil K.  Sood</span>, <span class="hlFld-ContribAuthor ">Robert L.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapy and Molecular Genetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 539-560.e6. <a href="https://doi.org/10.1016/B978-0-323-07419-3.00018-7" title="DOI URL">https://doi.org/10.1016/B978-0-323-07419-3.00018-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-07419-3.00018-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-07419-3.00018-7%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapy%252Band%252BMolecular%252BGenetics%26aulast%3DWestin%26aufirst%3DShannon%2BN.%26date%3D2012%26spage%3D539%26epage%3D560.e6%26pub%3DElsevier%26atitle%3DClinical%252BGynecologic%252BOncology%26date%3D2012%26volume%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald M. A.  Knegtel</span>, <span class="hlFld-ContribAuthor ">Daniel D.  Robinson</span>. </span><span class="cited-content_cbyCitation_article-title">A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2011,</strong> <em>30 </em>
                                    (11-12)
                                     , 950-959. <a href="https://doi.org/10.1002/minf.201100086" title="DOI URL">https://doi.org/10.1002/minf.201100086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201100086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201100086%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DA%252BRole%252Bfor%252BHydration%252Bin%252BInterleukin-2%252BInducible%252BT%252BCell%252BKinase%252B%252528Itk%252529%252BSelectivity%26aulast%3DKnegtel%26aufirst%3DRonald%2BM.%2BA.%26date%3D2011%26date%3D2011%26volume%3D30%26issue%3D11-12%26spage%3D950%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Antineoplastic Agents, 1. Nonhormonal. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,<a href="https://doi.org/10.1002/14356007.a05_001.pub2" title="DOI URL">https://doi.org/10.1002/14356007.a05_001.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_001.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_001.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAntineoplastic%252BAgents%25252C%252B1.%252BNonhormonal%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2011%26date%3D2011%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanna  Björkelund</span>, <span class="hlFld-ContribAuthor ">Lars  Gedda</span>, <span class="hlFld-ContribAuthor ">Pavel  Barta</span>, <span class="hlFld-ContribAuthor ">Magnus  Malmqvist</span>, <span class="hlFld-ContribAuthor ">Karl  Andersson</span>, . </span><span class="cited-content_cbyCitation_article-title">Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2011,</strong> <em>6 </em>
                                    (9)
                                     , e24739. <a href="https://doi.org/10.1371/journal.pone.0024739" title="DOI URL">https://doi.org/10.1371/journal.pone.0024739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0024739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0024739%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DGefitinib%252BInduces%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BDimers%252BWhich%252BAlters%252Bthe%252BInteraction%252BCharacteristics%252Bwith%252B125I-EGF%26aulast%3DBj%25C3%25B6rkelund%26aufirst%3DHanna%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D9%26spage%3De24739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Brünner-Kubath</span>, <span class="hlFld-ContribAuthor ">Waheed  Shabbir</span>, <span class="hlFld-ContribAuthor ">Victoria  Saferding</span>, <span class="hlFld-ContribAuthor ">Renate  Wagner</span>, <span class="hlFld-ContribAuthor ">Christian F.  Singer</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Brigitte  Marian</span>, <span class="hlFld-ContribAuthor ">Christoph C.  Zielinski</span>, <span class="hlFld-ContribAuthor ">Michael  Grusch</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Grunt</span>. </span><span class="cited-content_cbyCitation_article-title">The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2011,</strong> <em>129 </em>
                                    (2)
                                     , 387-400. <a href="https://doi.org/10.1007/s10549-010-1232-1" title="DOI URL">https://doi.org/10.1007/s10549-010-1232-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-010-1232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-010-1232-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DThe%252BPI3%252Bkinase%25252FmTOR%252Bblocker%252BNVP-BEZ235%252Boverrides%252Bresistance%252Bagainst%252Birreversible%252BErbB%252Binhibitors%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DBr%25C3%25BCnner-Kubath%26aufirst%3DCaroline%26date%3D2011%26date%3D2010%26volume%3D129%26issue%3D2%26spage%3D387%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lívia G. A.  Avelar</span>, <span class="hlFld-ContribAuthor ">Laila A.  Nahum</span>, <span class="hlFld-ContribAuthor ">Luiza F.  Andrade</span>, <span class="hlFld-ContribAuthor ">Guilherme  Oliveira</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Diversity of the
              Schistosoma mansoni
              Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Signal Transduction</span><span> <strong>2011,</strong> <em>2011 </em>, 1-11. <a href="https://doi.org/10.1155/2011/603290" title="DOI URL">https://doi.org/10.1155/2011/603290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2011/603290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2011%2F603290%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Signal%2520Transduction%26atitle%3DFunctional%252BDiversity%252Bof%252Bthe%252BSchistosoma%252Bmansoni%252BTyrosine%252BKinases%26aulast%3DAvelar%26aufirst%3DL%25C3%25ADvia%2BG.%2BA.%26date%3D2011%26volume%3D2011%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim M.  El-Deeb</span>, <span class="hlFld-ContribAuthor ">Su-Jin  Jung</span>, <span class="hlFld-ContribAuthor ">Byung-Sun  Park</span>, <span class="hlFld-ContribAuthor ">Young-Jun  Yoo</span>, <span class="hlFld-ContribAuthor ">Ki-Hang  Choi</span>, <span class="hlFld-ContribAuthor ">Young-Mok  Yang</span>, <span class="hlFld-ContribAuthor ">Sang-Woo  Lee</span>, <span class="hlFld-ContribAuthor ">In-Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Dong-Keun  Han</span>, <span class="hlFld-ContribAuthor ">So-Ha  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">A Highly Selective Staurosporine Derivative Designed by a New Selectivity Filter. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2011,</strong> <em>32 </em>
                                    (5)
                                     , 1709-1714. <a href="https://doi.org/10.5012/bkcs.2011.32.5.1709" title="DOI URL">https://doi.org/10.5012/bkcs.2011.32.5.1709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2011.32.5.1709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2011.32.5.1709%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DA%252BHighly%252BSelective%252BStaurosporine%252BDerivative%252BDesigned%252Bby%252Ba%252BNew%252BSelectivity%252BFilter%26aulast%3DEl-Deeb%26aufirst%3DIbrahim%2BM.%26date%3D2011%26volume%3D32%26issue%3D5%26spage%3D1709%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Cheng</span>, <span class="hlFld-ContribAuthor ">Thomas  Force</span>. </span><span class="cited-content_cbyCitation_article-title">Why do Kinase Inhibitors Cause Cardiotoxicity and What can be Done About It?. </span><span class="cited-content_cbyCitation_journal-name">Progress in Cardiovascular Diseases</span><span> <strong>2010,</strong> <em>53 </em>
                                    (2)
                                     , 114-120. <a href="https://doi.org/10.1016/j.pcad.2010.06.006" title="DOI URL">https://doi.org/10.1016/j.pcad.2010.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pcad.2010.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pcad.2010.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Cardiovascular%2520Diseases%26atitle%3DWhy%252Bdo%252BKinase%252BInhibitors%252BCause%252BCardiotoxicity%252Band%252BWhat%252Bcan%252Bbe%252BDone%252BAbout%252BIt%25253F%26aulast%3DCheng%26aufirst%3DHui%26date%3D2010%26volume%3D53%26issue%3D2%26spage%3D114%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arsénio M.  Fialho</span>, <span class="hlFld-ContribAuthor ">Ananda M.  Chakrabarty</span>. </span><span class="cited-content_cbyCitation_article-title">Promiscuous Anticancer Drugs from Pathogenic Bacteria: Rational Versus Intelligent Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 179-198. <a href="https://doi.org/10.1002/9780470626528.ch8" title="DOI URL">https://doi.org/10.1002/9780470626528.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470626528.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470626528.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DPromiscuous%252BAnticancer%252BDrugs%252Bfrom%252BPathogenic%252BBacteria%25253A%252BRational%252BVersus%252BIntelligent%252BDrug%252BDesign%26aulast%3DFialho%26aufirst%3DArs%25C3%25A9nio%2BM.%26date%3D2010%26date%3D2010%26spage%3D179%26epage%3D198%26pub%3DWiley%26atitle%3DEmerging%252BCancer%252BTherapy%26aulast%3DFialho%26aufirst%3DArs%25C3%25A9nio%2BM.%26date%3D2010%26date%3D2010%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Sonali  Kurup</span>, <span class="hlFld-ContribAuthor ">Michael A  Ihnat</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Satyendra S.  Shenoy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of N4-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (10)
                                     , 3575-3587. <a href="https://doi.org/10.1016/j.bmc.2010.03.052" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.03.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.03.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252BN4-phenylsubstituted-6-%2525282%25252C4-dichloro%252Bphenylmethyl%252529-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine-2%25252C4-diamines%252Bas%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor-2%252Binhibitors%252Band%252Bantiangiogenic%252Band%252Bantitumor%252Bagents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2010%26volume%3D18%26issue%3D10%26spage%3D3575%26epage%3D3587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel D.  Robinson</span>, <span class="hlFld-ContribAuthor ">Woody  Sherman</span>, <span class="hlFld-ContribAuthor ">Ramy  Farid</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (4)
                                     , 618-627. <a href="https://doi.org/10.1002/cmdc.200900501" title="DOI URL">https://doi.org/10.1002/cmdc.200900501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.200900501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.200900501%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnderstanding%252BKinase%252BSelectivity%252BThrough%252BEnergetic%252BAnalysis%252Bof%252BBinding%252BSite%252BWaters%26aulast%3DRobinson%26aufirst%3DDaniel%25E2%2580%2585D.%26date%3D2010%26volume%3D5%26issue%3D4%26spage%3D618%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuel  Raschi</span>, <span class="hlFld-ContribAuthor ">Valentina  Vasina</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Ursino</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Boriani</span>, <span class="hlFld-ContribAuthor ">Andrea  Martoni</span>, <span class="hlFld-ContribAuthor ">Fabrizio  De Ponti</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2010,</strong> <em>125 </em>
                                    (2)
                                     , 196-218. <a href="https://doi.org/10.1016/j.pharmthera.2009.10.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2009.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2009.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2009.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DAnticancer%252Bdrugs%252Band%252Bcardiotoxicity%25253A%252BInsights%252Band%252Bperspectives%252Bin%252Bthe%252Bera%252Bof%252Btargeted%252Btherapy%26aulast%3DRaschi%26aufirst%3DEmanuel%26date%3D2010%26volume%3D125%26issue%3D2%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher M.  Fraser</span>, <span class="hlFld-ContribAuthor ">Ariel  Fernández</span>, <span class="hlFld-ContribAuthor ">L. Ridgway  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Dehydron Analysis: Quantifying the Effect of Hydrophobic Groups on the Strength and Stability of Hydrogen Bonds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 473-479. <a href="https://doi.org/10.1007/978-1-4419-5913-3_53" title="DOI URL">https://doi.org/10.1007/978-1-4419-5913-3_53</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4419-5913-3_53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4419-5913-3_53%26sid%3Dliteratum%253Aachs%26atitle%3DDehydron%252BAnalysis%25253A%252BQuantifying%252Bthe%252BEffect%252Bof%252BHydrophobic%252BGroups%252Bon%252Bthe%252BStrength%252Band%252BStability%252Bof%252BHydrogen%252BBonds%26aulast%3DFraser%26aufirst%3DChristopher%2BM.%26date%3D2010%26date%3D2010%26spage%3D473%26epage%3D479%26pub%3DSpringer%2520New%2520York%26atitle%3DAdvances%252Bin%252BComputational%252BBiology%26aulast%3DArabnia%26aufirst%3DHamid%2BR.%26date%3D2010%26volume%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frauke  Alves</span>, <span class="hlFld-ContribAuthor ">Christian  Dullin</span>, <span class="hlFld-ContribAuthor ">Joanna  Napp</span>, <span class="hlFld-ContribAuthor ">Jeannine  Missbach-Guentner</span>, <span class="hlFld-ContribAuthor ">Katharina  Jannasch</span>, <span class="hlFld-ContribAuthor ">Julia  Mathejczyk</span>, <span class="hlFld-ContribAuthor ">Luis A.  Pardo</span>, <span class="hlFld-ContribAuthor ">Walter  Stühmer</span>, <span class="hlFld-ContribAuthor ">Lutz-F.  Tietze</span>. </span><span class="cited-content_cbyCitation_article-title">Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Radiology</span><span> <strong>2009,</strong> <em>70 </em>
                                    (2)
                                     , 286-293. <a href="https://doi.org/10.1016/j.ejrad.2009.01.048" title="DOI URL">https://doi.org/10.1016/j.ejrad.2009.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejrad.2009.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejrad.2009.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Radiology%26atitle%3DConcept%252Bof%252Ba%252Bselective%252Btumour%252Btherapy%252Band%252Bits%252Bevaluation%252Bby%252Bnear-infrared%252Bfluorescence%252Bimaging%252Band%252Bflat-panel%252Bvolume%252Bcomputed%252Btomography%252Bin%252Bmice%26aulast%3DAlves%26aufirst%3DFrauke%26date%3D2009%26volume%3D70%26issue%3D2%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary J.  Savage</span>, <span class="hlFld-ContribAuthor ">Diane E.  Gingrich</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2009,</strong> <em>70 </em>
                                    (2)
                                     , 125-144. <a href="https://doi.org/10.1002/ddr.20287" title="DOI URL">https://doi.org/10.1002/ddr.20287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.20287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.20287%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DAdvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bkinase%252Binhibitor%252Btherapeutics%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSavage%26aufirst%3DMary%2BJ.%26date%3D2009%26volume%3D70%26issue%3D2%26spage%3D125%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason P.  Covy</span>, <span class="hlFld-ContribAuthor ">Benoit I.  Giasson</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2009,</strong> <em>378 </em>
                                    (3)
                                     , 473-477. <a href="https://doi.org/10.1016/j.bbrc.2008.11.048" title="DOI URL">https://doi.org/10.1016/j.bbrc.2008.11.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2008.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2008.11.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DIdentification%252Bof%252Bcompounds%252Bthat%252Binhibit%252Bthe%252Bkinase%252Bactivity%252Bof%252Bleucine-rich%252Brepeat%252Bkinase%252B2%26aulast%3DCovy%26aufirst%3DJason%2BP.%26date%3D2009%26volume%3D378%26issue%3D3%26spage%3D473%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariel  Fernández</span>, <span class="hlFld-ContribAuthor ">Alejandro  Crespo</span>, <span class="hlFld-ContribAuthor ">Abhinav  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Is there a case for selectively promiscuous anticancer drugs?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2009,</strong> <em>14 </em>
                                    (1-2)
                                     , 1-5. <a href="https://doi.org/10.1016/j.drudis.2008.10.008" title="DOI URL">https://doi.org/10.1016/j.drudis.2008.10.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2008.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2008.10.008%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIs%252Bthere%252Ba%252Bcase%252Bfor%252Bselectively%252Bpromiscuous%252Banticancer%252Bdrugs%25253F%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DAriel%26date%3D2009%26volume%3D14%26issue%3D1-2%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0011.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Structures of Commercial Anticancer Drugs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0012.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Chemical Structures of Compounds <b>7</b> and <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0001.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Structures of Compounds <b>8</b> and <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ribbon representation of EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue) in complex with staurosporine. Relevant structural features that frame the ATP-pocket (white circle) are depicted for clarity: nucleotide-binding loop (red), P-loop (orange), αC-helix (yellow), catalytic loop (green), and activation loop (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Induced-fit conformation of the ATP-binding pocket of EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue) generated when crystallized with staurosporine. The ligand forms two hydrogen bonds with the conserved backbone atoms of residues in the nucleotide-binding loop (Q791 and M793) and hydrophobic interactions with residues framing the pocket (gatekeeper: T790). EGFR kinase has seven dehydrons (green virtual bond joining α-carbons) within its binding pocket: G721-F723 and G721-G724 in the P-loop, R776-Q791, M793-G796, P794-G796, and G796-V845 in the nucleotide-binding loop, and D855-G857 in the activation loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected aligned backbones (ribbon representation) of EGFR (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW">2ITW</a>, blue), PDPK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKY">1OKY</a>, red), and CDK2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1">1AQ1</a>, yellow) kinases complexed with compound <b>9</b>. The R776-Q791 dehydron in EGFR (green virtual bond joining α-carbons) maps into the well-wrapped backbone hydrogen bonds (gray virtual bonds joining α-carbons) K144−E160 in PDPK1 and K65-E81 in CDK2. The methyl group at the pyrrol N6-position (indicated by the green box) turns the ligand into a wrapper of the nonconserved dehydron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Affinity profile of compound <b>9</b>. High-throughput screening at 10 μM of <b>9</b> (red) over a battery of 220 human kinases displayed in a T7-bacteriophage-expressing library (Ambit Bioscience, San Diego, CA). The screening assay of staurosporine (blue) was used as control.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Hit values are reported as percentage bound kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural alignment of two targets of <b>8</b>: the EGFR kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17">1M17</a>, blue ribbon representation, atoms in balls and sticks) and the paralogue PAK1 kinase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHV">1YHV</a>, red ribbon representation, atoms licorice), complexed with the drug (licorice). Atoms are depicted following standard color convention (chlorine in green, fluorine in light green). The sources of promiscuity of compound <b>8</b> are the terminal acryl group (electrophile group in the Michael reaction) and its cyanide group (involved in intermolecular electrostatic interaction with a Thr or Met gatekeeper). EGFR has a poorly conserved D855-G857 dehydron (green virtual bond joining α-carbons) that may be targeted to achieve selectivity. PAK1 contains the same two promiscuity-fostering features, while it has a well-wrapped hydrogen bond aligned at such position (gray virtual bond joining α-carbons). Targeting such dehydron will ensure a discriminatory binding of EGFR without hitting PAK1, as experimentally corroborated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. EGFR kinase structure (same representation as Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) complexed with compound <b>10</b> (licorice representation). To remove promiscuity, the acrylic double bond (Michael electrophile) and the gatekeeper-interacting cyanide group of <b>8</b> are replaced by a single bond and a methyl group, respectively. To selectively target EGFR, another methyl group is added to the terminal benzene ring as a wrapper of the least conserved D855-G857 dehydron (green virtual bond joining α-carbons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Affinity profile of compound <b>10</b>. High-throughput screening at 10 μM of <b>10</b> (red) over a battery of 220 human kinases displayed in a T7-bacteriophage-expressing library (Ambit Bioscience, San Diego, CA). The screening assay of <b>8</b> (blue) was used as control.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Hit values are reported as percentage bound kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/medium/jm-2008-00453a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0002.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Pathway of Compound <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-16/jm800453a/production/images/large/jm-2008-00453a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800453a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Toluene, reflux. (b) Dowtherm, 256 °C. (c) POCl<sub>3</sub>, reflux. (d) Fe, NH<sub>4</sub>Cl, CH<sub>3</sub>OH, reflux. (e) <i>N,N</i>-diisopropylethylamine, THF, 0 °C. See <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> for details.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gibbs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliff, A.</span><span> </span><span class="NLM_article-title">Pharmaceutical research in molecular oncology</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">193</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=193-198&author=J.+Gibbsauthor=A.+Oliff&title=Pharmaceutical+research+in+molecular+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DJ.%26aulast%3DOliff%26aufirst%3DA.%26atitle%3DPharmaceutical%2520research%2520in%2520molecular%2520oncology%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Levitski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazit, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibition: an approach to drug development</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">267</span> <span class="NLM_fpage">1782</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1995&pages=1782-1788&author=A.+Levitskiauthor=A.+Gazit&title=Tyrosine+kinase+inhibition%3A+an+approach+to+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitski%26aufirst%3DA.%26aulast%3DGazit%26aufirst%3DA.%26atitle%3DTyrosine%2520kinase%2520inhibition%253A%2520an%2520approach%2520to%2520drug%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D267%26spage%3D1782%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Donato, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span> </span><span class="NLM_article-title">Clinical use of tyrosine kinase inhibitors: therapy for chronic myelogenous leukemia and other cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">2965</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=10955770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FmtVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2965-2966&author=N.+J.+Donatoauthor=M.+Talpaz&title=Clinical+use+of+tyrosine+kinase+inhibitors%3A+therapy+for+chronic+myelogenous+leukemia+and+other+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical use of tyrosine kinase inhibitors: therapy for chronic myelogenous leukemia and other cancers</span></div><div class="casAuthors">Donato N J; Talpaz M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2965-6</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThES6kKGIwE0NoizSOkG_FfW6udTcc2eaM0nFAqHvq2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FmtVWjug%253D%253D&md5=c9058bdfa50e3b511889a211c9eb50e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26atitle%3DClinical%2520use%2520of%2520tyrosine%2520kinase%2520inhibitors%253A%2520therapy%2520for%2520chronic%2520myelogenous%2520leukemia%2520and%2520other%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2965%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dancey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Issues and progress with protein kinase inhibitors for cancer treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">296</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrd1066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12669029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=296-313&author=J.+Danceyauthor=E.+A.+Sausville&title=Issues+and+progress+with+protein+kinase+inhibitors+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Issues and progress with protein kinase inhibitors for cancer treatment</span></div><div class="casAuthors">Dancey, Janet; Sausville, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">296-313</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Identification of the key roles of protein kinases in cancer has led to extensive efforts to develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 such agents are now in clin. trials.  Here, we consider the crucial issues in the development of kinase inhibitors for cancer, and discuss strategies to address the challenges raised by these issues in the light of preclin. and clin. experiences so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-u-kzpegLrVg90H21EOLACvtfcHk0ljb9CiXFllqew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWkt70%253D&md5=fb11803282bcc39b24fa238a6ab973c8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1066%26sid%3Dliteratum%253Aachs%26aulast%3DDancey%26aufirst%3DJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DIssues%2520and%2520progress%2520with%2520protein%2520kinase%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D296%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tibes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=357-384&author=R.+Tibesauthor=J.+Trentauthor=R.+Kurzrock&title=Tyrosine+kinase+inhibitors+and+the+dawn+of+molecular+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTibes%26aufirst%3DR.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTyrosine%2520kinase%2520inhibitors%2520and%2520the%2520dawn%2520of%2520molecular%2520cancer%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D357%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Molecular basis for specificity in the druggable kinome: sequence-based analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">23</span> <span class="NLM_fpage">563</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=563-572&author=J.+Chenauthor=X.+Zhangauthor=A.+Fern%C3%A1ndez&title=Molecular+basis+for+specificity+in+the+druggable+kinome%3A+sequence-based+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DMolecular%2520basis%2520for%2520specificity%2520in%2520the%2520druggable%2520kinome%253A%2520sequence-based%2520analysis%26jtitle%3DBioinformatics%26date%3D2007%26volume%3D23%26spage%3D563%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">621</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0liald0aNX31Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirrankar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. A.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">23</span> <span class="NLM_fpage">329</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+A.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgandauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zirrankarauthor=D.+A.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0liald0aNX31Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BA.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgand%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZirrankar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BA.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Karaman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">26</span> <span class="NLM_fpage">127</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+K.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0li8pYDk3ndVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BK.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapy: have floodgates opened</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">357</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=357-360&author=B.+J.+Druker&title=Molecularly+targeted+therapy%3A+have+floodgates+opened"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DMolecularly%2520targeted%2520therapy%253A%2520have%2520floodgates%2520opened%26jtitle%3DOncologist%26date%3D2004%26volume%3D9%26spage%3D357%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kerkelä, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">908</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkel%C3%A4author=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2eZys5FooPkz0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkel%25C3%25A4%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Force, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">332</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrc2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=17457301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=332-344&author=T.+Forceauthor=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Molecular+mechanisms+of+cardiotoxicity+of+tyrosine+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span></div><div class="casAuthors">Force, Thomas; Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-344</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer therapy has progressed remarkably in recent years.  In no area has this been more apparent than in the development of 'targeted therapies', particularly those using drugs that inhibit the activity of certain tyrosine kinases, activating mutations or amplifications of which are causal, or strongly contributory, to tumorigenesis.  However, some of these therapies have been assocd. with toxicity to the heart.  Here we summarize what is known about the cardiotoxicity of cancer drugs that target tyrosine kinases.  We focus on basic mechanisms through which interruption of specific signalling pathways leads to cardiomyocyte dysfunction and/or death, and contrast this with therapeutic responses in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyJIGdG9hv7Vg90H21EOLACvtfcHk0lj_wR67yAQzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D&md5=b574f420e2a09de9bae3aa2313e76c3e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2106%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520cardiotoxicity%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D332%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, A.</span><span> </span><span class="NLM_article-title">Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">493</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2Fnrd839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12120256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=493-502&author=R.+Capdevilleauthor=E.+Buchdungerauthor=J.+Zimmermannauthor=A.+Matter&title=Glivec+%28STI571%2C+imatinib%29%2C+a+rationally+developed%2C+targeted+anticancer+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</span></div><div class="casAuthors">Capdeville, Renaud; Buchdunger, Elisabeth; Zimmermann, Juerg; Matter, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-502</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the early 1980s, it became apparent that the work of pioneers such as Robert Weinberg, Mariano Barbacid and many others in identifying cancer-causing genes in humans was opening the door to a new era in anticancer research.  Motivated by this, and by dissatisfaction with the limited efficacy and tolerability of available anticancer modalities, a drug discovery program was initiated with the aim of rationally developing targeted anticancer therapies.  Here, we describe how this program led to the discovery and continuing development of Glivec (Gleevec in the United States), the first selective tyrosine-kinase inhibitor to be approved for the treatment of a cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeI0HV4de6ObVg90H21EOLACvtfcHk0lj_wR67yAQzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKlurY%253D&md5=c8f6b7a66f74b64f0dedb5e641097acc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd839%26sid%3Dliteratum%253Aachs%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DMatter%26aufirst%3DA.%26atitle%3DGlivec%2520%2528STI571%252C%2520imatinib%2529%252C%2520a%2520rationally%2520developed%252C%2520targeted%2520anticancer%2520drug%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D493%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Atkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Sunitinib maleate</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">279</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=279-280&author=M.+Atkinsauthor=C.+A.+Jonesauthor=P.+Kirkpatrick&title=Sunitinib+maleate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DSunitinib%2520maleate%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D279%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Sorafenib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">453</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1517%2F14656566.7.4.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16503817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=453-461&author=B.+I.+Rini&title=Sorafenib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-461</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Sorafenib is a small mol. inhibitor of several kinases involved in tumor proliferation and tumor angiogenesis including Raf, VEGFR and platelet derived growth factor receptor.  In vivo Raf kinase inhibition has been obsd. in pharmacodynamic studies.  Sorafenib is one of several VEGF-targeting compds. with recently demonstrated substantial anti-tumor effects in metastatic renal cell carcinoma.  Delay in time to disease progression has been demonstrated in cytokine-refractory metastatic renal cell carcinoma, and further investigation is ongoing in a wide variety of tumor types.  Sorafenib is well tolerated, with common toxicities including rash, diarrhea, hand-foot skin reaction, fatigue and hypertension, when administered as the std. dose of 400 mg b.i.d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTbL_e_cFYVbVg90H21EOLACvtfcHk0lidy7zZ7K5QYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVKgu78%253D&md5=07dddaf18041f4885a535485fa0dfa8a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.4.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.4.453%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DSorafenib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D453%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">McIntyre, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Er, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayes, M.</span><span> </span><span class="NLM_article-title">Dasatinib. Treatment of leukemia treatment of solid tumors Bcr-Abl and Src kinase inhibitor</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">291</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1358%2Fdof.2006.031.04.984426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=291-303&author=J.+A.+McIntyreauthor=J.+Erauthor=M.+Bayes&title=Dasatinib.+Treatment+of+leukemia+treatment+of+solid+tumors+Bcr-Abl+and+Src+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dasatinib: treatment of leukemia treatment of solid tumors Bcr-Abl and Src kinase inhibitor</span></div><div class="casAuthors">McIntyre, J. A.; Castaner, J.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-303</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Chronic myelogenous leukemia (CML) results from a single mutagenic event leading to acquisition of the Philadelphia chromosome abnormality and the BCR-ABL fusion gene.  Improved understanding of the mol. mechanisms of resistance in CML led to the discovery of the small-mol., dual Bcr-Abl and Src kinase inhibitor dasatinib (BMS-354825).  Dasatinib has 325-fold increased potency relative to imatinib and has demonstrated activity against a wide range of clin. relevant isoforms resistant to imatinib.  In a mouse model of imatinib-resistant, Bcr-Abl-dependent disease, dasatinib significantly prolonged survival.  It also demonstrated potent activity against cell lines overexpressing Src and Kit tyrosine kinases.  Preclin. studies have shown that dasatinib may also be active against solid malignancies, including breast and prostate carcinoma.  In phase I and II studies in patients with chronic-phase, accelerated-phase and myeloid blast crisis CML and Philadelphia chromosome-pos. acute lymphoblastic leukemia (Ph+ ALL) with hematol. resistance or intolerance to imatinib, durable responses were obtained, as well as cytogenetic responses in patients with a wide spectrum of Bcr-Abl mutations.  Regulatory submissions have been made in the U.S. and the E.G. for its use in CML and Ph+ ALL patients resistant or intolerant to prior therapy, and clin. studies are under way in several solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjM_YUwPgpdLVg90H21EOLACvtfcHk0lidy7zZ7K5QYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsLY%253D&md5=7a7d5e10b4f946b93fb939f5667cdbe9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.984426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.984426%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntyre%26aufirst%3DJ.%2BA.%26aulast%3DEr%26aufirst%3DJ.%26aulast%3DBayes%26aufirst%3DM.%26atitle%3DDasatinib.%2520Treatment%2520of%2520leukemia%2520treatment%2520of%2520solid%2520tumors%2520Bcr-Abl%2520and%2520Src%2520kinase%2520inhibitor%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D291%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Leighl, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Res, D.</span><span> </span><span class="NLM_article-title">Erlotinib: Profile report</span> <span class="citation_source-journal">Drugs Ther. Perspect.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=1-2&author=N.+B.+Leighlauthor=D.+Res&title=Erlotinib%3A+Profile+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeighl%26aufirst%3DN.%2BB.%26aulast%3DRes%26aufirst%3DD.%26atitle%3DErlotinib%253A%2520Profile%2520report%26jtitle%3DDrugs%2520Ther.%2520Perspect.%26date%3D2006%26volume%3D22%26spage%3D1%26epage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cancellieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trisolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Clinical experience with gefitinib: An update</span> <span class="citation_source-journal">CRC Crit. Rev. Oncol. Hematol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">31</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1016%2Fj.critrevonc.2005.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16531062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A280%3ADC%252BD287lvFyguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=31-45&author=F.+Cappuzzoauthor=G.+Finocchiaroauthor=G.+Metroauthor=S.+Bartoliniauthor=E.+Magriniauthor=A.+Cancellieriauthor=R.+Trisoliniauthor=L.+Castaldiniauthor=G.+Talliniauthor=L.+Crino&title=Clinical+experience+with+gefitinib%3A+An+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience with gefitinib: an update</span></div><div class="casAuthors">Cappuzzo Federico; Finocchiaro Giovanna; Metro Giulio; Bartolini Stefania; Magrini Elisabetta; Cancellieri Alessandra; Trisolini Rocco; Castaldini Luciano; Tallini Giovanni; Crino Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-45</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Gefitinib is an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that blocks signal transduction pathways involved in cell proliferation.  This drug demonstrated impressive and durable responses in patients with heavily pretreated non-small cell lung cancer (NSCLC).  In two large phase II trials, responses were observed in 9-19% of unselected patients, along with symptom improvement and benefit in quality of life.  Biological mechanisms underlying TKI sensitivity have recently been discovered.  There is evidence that specific EGFR gene mutations and/or amplification confer a particularly sensitive phenotype, especially in individuals with tumors demonstrating activation of the anti-apoptotic protein Akt.  However, in all so far conducted clinical trials, no patient selection has been made, providing a logical explanation for the negative results observed in large phase III studies.  In the present review, we will summarize the results observed in clinical trials with gefitinib.  We will present results obtained in NSCLC and in other solid tumor, focusing on biological and clinical markers predicting drug sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnml1a0EdLEXthwrmtH4OBfW6udTcc2eauaMF5Oeskm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287lvFyguw%253D%253D&md5=25114c49601a100d0a66b2e7b306bf37</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2005.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2005.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DBartolini%26aufirst%3DS.%26aulast%3DMagrini%26aufirst%3DE.%26aulast%3DCancellieri%26aufirst%3DA.%26aulast%3DTrisolini%26aufirst%3DR.%26aulast%3DCastaldini%26aufirst%3DL.%26aulast%3DTallini%26aufirst%3DG.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DClinical%2520experience%2520with%2520gefitinib%253A%2520An%2520update%26jtitle%3DCRC%2520Crit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2006%26volume%3D58%26spage%3D31%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozturk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shavrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangala, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelovani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span> </span><span class="NLM_article-title">An anticancer C-kit kinase inhibitor is re-engineered to make it more active and less cardiotoxic</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">4044</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=4044-4054&author=A.+Fern%C3%A1ndezauthor=A.+Sanguinoauthor=Z.+Pengauthor=E.+Ozturkauthor=J.+Chenauthor=A.+Crespoauthor=S.+Wulfauthor=A.+Shavrinauthor=C.+Qinauthor=J.+Maauthor=J.+Trentauthor=Y.+Linauthor=H.+Hanauthor=L.+S.+Mangalaauthor=J.+A.+Banksonauthor=J.+Gelovaniauthor=A.+Samarelauthor=W.+Bornmannauthor=A.+K.+Soodauthor=G.+L%C3%B3pez-Berestein&title=An+anticancer+C-kit+kinase+inhibitor+is+re-engineered+to+make+it+more+active+and+less+cardiotoxic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DSanguino%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DOzturk%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DShavrin%26aufirst%3DA.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DMangala%26aufirst%3DL.%2BS.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DGelovani%26aufirst%3DJ.%26aulast%3DSamarel%26aufirst%3DA.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26atitle%3DAn%2520anticancer%2520C-kit%2520kinase%2520inhibitor%2520is%2520re-engineered%2520to%2520make%2520it%2520more%2520active%2520and%2520less%2520cardiotoxic%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D4044%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Demetri, G.</span><span> </span><span class="NLM_article-title">Structural reengineering of imatinib to decrease cardiac risk in cancer therapy</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">3650</span> <span class="NLM_lpage">3653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3650-3653&author=G.+Demetri&title=Structural+reengineering+of+imatinib+to+decrease+cardiac+risk+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%26atitle%3DStructural%2520reengineering%2520of%2520imatinib%2520to%2520decrease%2520cardiac%2520risk%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3650%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Crunkhorn, S.</span><span> </span><span class="NLM_article-title">Anticancer drugs: Redesigning kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">120</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=120-121&author=S.+Crunkhorn&title=Anticancer+drugs%3A+Redesigning+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrunkhorn%26aufirst%3DS.%26atitle%3DAnticancer%2520drugs%253A%2520Redesigning%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D120%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Kinase packing defects as drug targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">917</span> <span class="NLM_lpage">923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=917-923&author=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Kinase+packing+defects+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DKinase%2520packing%2520defects%2520as%2520drug%2520targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D917%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheraga, H. A.</span><span> </span><span class="NLM_article-title">Insufficiently dehydrated hydrogen bonds as determinants of protein interactions</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">100</span> <span class="NLM_fpage">113</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=113-118&author=A.+Fern%C3%A1ndezauthor=H.+A.+Scheraga&title=Insufficiently+dehydrated+hydrogen+bonds+as+determinants+of+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScheraga%26aufirst%3DH.%2BA.%26atitle%3DInsufficiently%2520dehydrated%2520hydrogen%2520bonds%2520as%2520determinants%2520of%2520protein%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. R.</span><span> </span><span class="NLM_article-title">Adherence of packing defects in soluble proteins</span> <span class="citation_source-journal">Phys. Rev. Lett.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">91</span><span class="NLM_elocation-id">018102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&author=A.+Fern%C3%A1ndezauthor=L.+R.+Scott&title=Adherence+of+packing+defects+in+soluble+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DL.%2BR.%26atitle%3DAdherence%2520of%2520packing%2520defects%2520in%2520soluble%2520proteins%26jtitle%3DPhys.%2520Rev.%2520Lett.%26date%3D2003%26volume%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. R.</span><span> </span><span class="NLM_article-title">Dehydron: A structurally encoded signal for protein interaction</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">85</span> <span class="NLM_fpage">1914</span> <span class="NLM_lpage">1928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=1914-1928&author=A.+Fern%C3%A1ndezauthor=L.+R.+Scott&title=Dehydron%3A+A+structurally+encoded+signal+for+protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DL.%2BR.%26atitle%3DDehydron%253A%2520A%2520structurally%2520encoded%2520signal%2520for%2520protein%2520interaction%26jtitle%3DBiophys.%2520J.%26date%3D2003%26volume%3D85%26spage%3D1914%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Keeping dry and crossing membranes</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">1081</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=1081-1084&author=A.+Fern%C3%A1ndez&title=Keeping+dry+and+crossing+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DKeeping%2520dry%2520and%2520crossing%2520membranes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2004%26volume%3D22%26spage%3D1081%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pietrosemoli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Dehydration propensity of order−disorder intermediate regions in soluble proteins</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">3519</span> <span class="NLM_lpage">3526</span></span><div class="citationLinks">[<a href="/doi/10.1021/pr070208k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVWitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3519-3526&author=N.+Pietrosemoliauthor=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Dehydration+propensity+of+order%E2%88%92disorder+intermediate+regions+in+soluble+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dehydration Propensity of Order-Disorder Intermediate Regions in Soluble Proteins</span></div><div class="casAuthors">Pietrosemoli, Natalia; Crespo, Alejandro; Fernandez, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3519-3526</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. folded proteins maintain their structural integrity by properly shielding most backbone amides and carbonyls from full hydration.  This structure "wrapping" entails a proper packing of the intramol. hydrogen bonds.  Thus, a poorly wrapped hydrogen bond constitutes an identifiable packing defect.  Such defects are promoters of protein assocns. since they favor the removal of hydrating mols.  In this work we show that large clusters of packing defects generate the most significant dehydration hot spots on the protein surface, inducing a strong dielec. modulation that is reflected by a local quenching of the dielec. permittivity.  The PDB-reported proteins with the largest clusters of packing defects are found to be three cancer-related transcription factors, four highly interactive proteins related to cell signaling and cytoskeleton, and a cellular prion protein.  A large concn. of packing defects in a sol. protein constitutes a structural singularity that is intermediate between order and disorder.  The functional implications of this singularity are investigated to delineate diverse interrelated roles.  The presence of these large clusters signals a structural vulnerability, a pronounced dehydration propensity, and a strong electrostatic enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogFSuxX6w_v7Vg90H21EOLACvtfcHk0liIvPi9oF8xQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVWitLw%253D&md5=95ecc607f01ab42a7cc72802d10cf08b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fpr070208k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr070208k%26sid%3Dliteratum%253Aachs%26aulast%3DPietrosemoli%26aufirst%3DN.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DDehydration%2520propensity%2520of%2520order%25E2%2588%2592disorder%2520intermediate%2520regions%2520in%2520soluble%2520proteins%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2007%26volume%3D6%26spage%3D3519%26epage%3D3526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Incomplete protein packing as a selectivity filter in drug design</span> <span class="citation_source-journal">Structure</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1829</span> <span class="NLM_lpage">1836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1829-1836&author=A.+Fern%C3%A1ndez&title=Incomplete+protein+packing+as+a+selectivity+filter+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DIncomplete%2520protein%2520packing%2520as%2520a%2520selectivity%2520filter%2520in%2520drug%2520design%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26spage%3D1829%26epage%3D1836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozturk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span> </span><span class="NLM_article-title">Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">4028</span> <span class="NLM_lpage">4033</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4028-4033&author=A.+Fern%C3%A1ndezauthor=A.+Sanguinoauthor=Z.+Pengauthor=A.+Crespoauthor=E.+Ozturkauthor=X.+Zhangauthor=S.+Wangauthor=W.+Bornmannauthor=G.+L%C3%B3pez-Berestein&title=Rational+drug+redesign+to+overcome+drug+resistance+in+cancer+therapy%3A+imatinib+moving+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DSanguino%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DOzturk%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26atitle%3DRational%2520drug%2520redesign%2520to%2520overcome%2520drug%2520resistance%2520in%2520cancer%2520therapy%253A%2520imatinib%2520moving%2520target%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4028%26epage%3D4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, R. S.</span><span> </span><span class="NLM_article-title">Molecular dimension explored in evolution to promote proteomic complexity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">101</span> <span class="NLM_fpage">13460</span> <span class="NLM_lpage">13465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=13460-13465&author=A.+Fern%C3%A1ndezauthor=R.+S.+Berry&title=Molecular+dimension+explored+in+evolution+to+promote+proteomic+complexity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520dimension%2520explored%2520in%2520evolution%2520to%2520promote%2520proteomic%2520complexity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D13460%26epage%3D13465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Link, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghavan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danishefsky, S. J.</span><span> </span><span class="NLM_article-title">First total synthesis of staurosporine and ent-staurosporine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">117</span> <span class="NLM_fpage">552</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00106a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=552-553&author=J.+T.+Linkauthor=S.+Raghavanauthor=S.+J.+Danishefsky&title=First+total+synthesis+of+staurosporine+and+ent-staurosporine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja00106a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00106a072%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BT.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DFirst%2520total%2520synthesis%2520of%2520staurosporine%2520and%2520ent-staurosporine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D552%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">49</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.+Wangauthor=L.+M.+Greenbergerauthor=H.+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddipati, S.</span><span> </span><span class="NLM_article-title">The a priori inference of cross reactivity for drug-targeted kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">3092</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060163j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3092-3100&author=A.+Fern%C3%A1ndezauthor=S.+Maddipati&title=The+a+priori+inference+of+cross+reactivity+for+drug-targeted+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060163j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060163j%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DMaddipati%26aufirst%3DS.%26atitle%3DThe%2520a%2520priori%2520inference%2520of%2520cross%2520reactivity%2520for%2520drug-targeted%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3092%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhoud, B. S.</span><span> </span><span class="NLM_article-title">Structural basis for Chk1 inhibition by UCN-01</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">277</span> <span class="NLM_fpage">46609</span> <span class="NLM_lpage">46615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1074%2Fjbc.M201233200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12244092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46609-46615&author=B.+Zhaoauthor=M.+J.+Bowerauthor=P.+J.+McDevittauthor=H.+Zhaoauthor=S.+T.+Davisauthor=K.+O.+Johansonauthor=S.+M.+Greenauthor=N.+O.+Conchaauthor=B.+S.+Zhoud&title=Structural+basis+for+Chk1+inhibition+by+UCN-01"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Chk1 Inhibition by UCN-01</span></div><div class="casAuthors">Zhao, Baoguang; Bower, Michael J.; McDevitt, Patrick J.; Zhao, Huizhen; Davis, Stephen T.; Johanson, Kyung O.; Green, Susan M.; Concha, Nestor O.; Zhou, Bin-Bing S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46609-46615</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chk1 is a serine-threonine kinase that plays an important role in the DNA damage response, including G2/M cell cycle control.  UCN-01 (7-hydroxystaurosporine), currently in clin. trials, has recently been shown to be a potent Chk1 inhibitor that abrogates the G2/M checkpoint induced by DNA-damaging agents.  To understand the structural basis of Chk1 inhibition by UCN-01, we detd. the crystal structure of the Chk1 kinase domain in complex with UCN-01.  Chk1 structures with staurosporine and its analog SB-218078 were also detd.  All three compds. bind in the ATP-binding pocket of Chk1, producing only slight changes in the protein conformation.  Selectivity of UCN-01 toward Chk1 over cyclin-dependent kinases can be explained by the presence of a hydroxyl group in the lactam moiety interacting with the ATP-binding pocket.  Hydrophobic interactions and hydrogen-bonding interactions were obsd. in the structures between UCN-01 and the Chk1 kinase domain.  The high structural complementarity of these interactions is consistent with the potency and selectivity of UCN-01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6biZWQjRI0rVg90H21EOLACvtfcHk0lhfFzNLW9mBJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D&md5=bc5ab22df94aa4f458f752a808d49a92</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201233200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201233200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DP.%2BJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DJohanson%26aufirst%3DK.%2BO.%26aulast%3DGreen%26aufirst%3DS.%2BM.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DZhoud%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520basis%2520for%2520Chk1%2520inhibition%2520by%2520UCN-01%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46609%26epage%3D46615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Dieckmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienaber, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajashankar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span> </span><span class="NLM_article-title">Novel mode of Gleevec binding is revealed by the structure of Spleen Tyrosine Kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">279</span> <span class="NLM_fpage">55827</span> <span class="NLM_lpage">55832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+M%C3%BCller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=Novel+mode+of+Gleevec+binding+is+revealed+by+the+structure+of+Spleen+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DM%25C3%25BCller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DNovel%2520mode%2520of%2520Gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520Spleen%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spehner, J. C.</span><span> </span><span class="NLM_article-title">Reduced surface: An efficient way to compute molecular surfaces</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">305</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1002%2F%28SICI%291097-0282%28199603%2938%3A3%3C305%3A%3AAID-BIP4%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=8906967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADyaK28XhtlOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=305-320&author=M.+F.+Sannerauthor=A.+J.+Olsonauthor=J.+C.+Spehner&title=Reduced+surface%3A+An+efficient+way+to+compute+molecular+surfaces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced surface: an efficient way to compute molecular surfaces</span></div><div class="casAuthors">Sanner, Michel F.; Olson, Arthur J.; Spehner, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-20</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Because of their wide use in mol. modeling, methods to compute mol. surfaces have received a lot of interest in recent years.  However, most of the proposed algorithms compute the anal. representation of only the solvent-accessible surface.  There are a few programs that compute the anal. representation of the solvent-excluded surface, but they often have problems handling singular cases of self-intersecting surfaces and tend to fail on large mols. (more than 10,000 atoms).  We describe here a program called MSMS, which is shown to be fast and reliable in computing mol. surfaces.  It relies on the use of the reduced surface that is briefly defined here and from which the solvent-accessible and solvent-excluded surfaces are computed.  The four algorithms composing MSMS are described and their complexity is analyzed.  Special attention is given to the handling of self-intersecting parts of the solvent-excluded surface singularities.  The program has been compared with Connolly's program PQMS [M. L. Connolly (1993) Journal of mol. Graphics, Vol. 11, pp 139-141] on a set of 709 mols. taken from the Brookhaven Data Base.  MSMS was able to compute topol. correct surfaces for each mol. in the set.  Moreover, the actual time spent to compute surfaces is in agreement with the theor. complexity of the program, which is shown to be O[n log(n)] for n atoms.  On a Hewlett-Packard 9000/735 workstation, MSMS takes 0.73 s to produce a triangulated solvent-excluded surface for crambin (1crn, 46 residues, 327 atoms, 4772 triangles), 4.6 s for thermolysin (3tln, 316 residues, 2437 atoms, 26462 triangles), and 104.53 s for glutamine synthetase (2gls, 5676 residues, 43632 atoms, 476665 triangles).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHh9yYKrEtzbVg90H21EOLACvtfcHk0ljlZpzp6i9JgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtlOisro%253D&md5=5d219165a50709300cebc0853afb1dd3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199603%2938%3A3%3C305%3A%3AAID-BIP4%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199603%252938%253A3%253C305%253A%253AAID-BIP4%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DSpehner%26aufirst%3DJ.%2BC.%26atitle%3DReduced%2520surface%253A%2520An%2520efficient%2520way%2520to%2520compute%2520molecular%2520surfaces%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D305%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Knölker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span> </span><span class="NLM_article-title">Isolation and synthesis of biologically active carbazole alkaloids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">102</span> <span class="NLM_fpage">4303</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr020059j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4303-4427&author=H.+J.+Kn%C3%B6lkerauthor=K.+R.+Reddy&title=Isolation+and+synthesis+of+biologically+active+carbazole+alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr020059j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020059j%26sid%3Dliteratum%253Aachs%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26atitle%3DIsolation%2520and%2520synthesis%2520of%2520biologically%2520active%2520carbazole%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4303%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span> <span class="citation_source-journal">N. Engl. J. Med</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">347</span> <span class="NLM_fpage">472</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1056%2FNEJMoa020461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=12181401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=472-480&author=G.+D.+Demetriauthor=M.+von+Mehrenauthor=C.+D.+Blankeauthor=A.+D.+Van+den+Abbeeleauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=M.+C.+Heinrichauthor=D.+A.+Tuvesonauthor=S.+Singerauthor=M.+Janicekauthor=J.+A.+Fletcherauthor=S.+G.+Silvermanauthor=S.+L.+Silbermanauthor=R.+Capdevilleauthor=B.+Kieseauthor=B.+Pengauthor=S.+Dimitrijevicauthor=B.+J.+Drukerauthor=C.+Corlessauthor=C.+D.+M.+Fletcherauthor=H.+Joensuu&title=Efficacy+and+safety+of+imatinib+mesylate+in+advanced+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span></div><div class="casAuthors">Demetri, George D.; von Mehren, Margaret; Blanke, Charles D.; Van den Abbeele, Annick D.; Eisenberg, Burton; Roberts, Peter J.; Heinrich, Michael C.; Tuveson, David A.; Singer, Samuel; Janicek, Milos; Fletcher, Jonathan A.; Silverman, Stuart G.; Silberman, Sandra L.; Capdeville, Renaud; Kiese, Beate; Peng, Bin; Dimitrijevic, Sasa; Druker, Brian J.; Corless, Christopher; Fletcher, Christopher D. M.; Joensuu, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Constitutive activation of KIT receptor tyrosine kinase is crit. in the pathogenesis of gastrointestinal stromal tumors.  Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclin. models and preliminary clin. studies to have activity against such tumors.  We conducted an open-label, randomized, multicenter trial to evaluate the activity of imatinib in patients with advanced gastrointestinal stromal tumor.  We assessed antitumor response and the safety and tolerability of the drug.  Pharmacokinetics were assessed in a subgroup of patients.  A total of 147 patients were randomly assigned to receive 400 mg or 600 mg of imatinib daily.  Overall, 79 patients (53.7 percent) had a partial response, 41 patients (27.9 percent) had stable disease, and for tech. reasons, response could not be evaluated in 7 patients (4.8 percent).  No patient had a complete response to the treatment.  The median duration of response had not been reached after a median follow-up of 24 wk after the onset of response.  Early resistance to imatinib was noted in 20 patients (13.6 percent).  Therapy was well tolerated, although mild-to-moderate edema, diarrhea, and fatigue were common.  Gastrointestinal or intraabdominal hemorrhage occurred in approx. 5 percent of patients.  There were no significant differences in toxic effects or response between the two doses.  Imatinib was well absorbed, with pharmacokinetics similar to those reported in patients with chronic myeloid leukemia.  Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor.  Inhibition of the KIT signal-transduction pathway is a promising treatment for advanced gastrointestinal stromal tumors, which resist conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVE0HpuuKXXrVg90H21EOLACvtfcHk0ljlZpzp6i9JgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D&md5=95c9ea076dd2b0e053ae2061cb3f5d24</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020461%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DJanicek%26aufirst%3DM.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DSilverman%26aufirst%3DS.%2BG.%26aulast%3DSilberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DCorless%26aufirst%3DC.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%2BM.%26aulast%3DJoensuu%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520imatinib%2520mesylate%2520in%2520advanced%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med%26date%3D2002%26volume%3D347%26spage%3D472%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Halder, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Therapeutic efficacy of a novel FAK inhibitor TAE226 in ovarian carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">10976</span> <span class="NLM_lpage">10983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10976-10983&author=J.+B.+Halderauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=W.+A.+Spannuthauthor=A.+M.+Nickauthor=T.+Hondaauthor=A.+A.+Kamatauthor=L.+Hanauthor=T.+J.+Kimauthor=C.+Luauthor=A.+M.+Tariauthor=W.+Bornmannauthor=A.+Fern%C3%A1ndezauthor=G.+L%C3%B3pez-Beresteinauthor=A.+K.+Sood&title=Therapeutic+efficacy+of+a+novel+FAK+inhibitor+TAE226+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%2BB.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DNick%26aufirst%3DA.%2BM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DTherapeutic%2520efficacy%2520of%2520a%2520novel%2520FAK%2520inhibitor%2520TAE226%2520in%2520ovarian%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10976%26epage%3D10983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">FRNK blocks v-Src stimulated invasion and experimental metastasis without effects on cell motility or growth</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">21</span> <span class="NLM_fpage">6289</span> <span class="NLM_lpage">6302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6289-6302&author=C.+R.+Hauckauthor=D.+A.+Hsiaauthor=X.+S.+Puenteauthor=D.+A.+Chereshauthor=D.+D.+Schlaepfer&title=FRNK+blocks+v-Src+stimulated+invasion+and+experimental+metastasis+without+effects+on+cell+motility+or+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DFRNK%2520blocks%2520v-Src%2520stimulated%2520invasion%2520and%2520experimental%2520metastasis%2520without%2520effects%2520on%2520cell%2520motility%2520or%2520growth%26jtitle%3DEMBO%2520J.%26date%3D2002%26volume%3D21%26spage%3D6289%26epage%3D6302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Torrance, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">1024</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0lj3My-kwrW8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1024%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorusi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">2252</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm800453a&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm800453a&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm800453a&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boniauthor=P.+Martinsauthor=S.+E.+Quinnauthor=C.+Zacharchukauthor=P.+Amorusiauthor=A.+A.+Adjeiauthor=E.+K.+Rowinsky&title=Phase+I+study+of+EKB-569%2C+an+irreversible+inhibitor+of+the+epidermal+growth+factor+receptor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean ± std. deviation terminal half-life was 21.7 ± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0lj3My-kwrW8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26aulast%3DMartins%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DS.%2BE.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DAmorusi%26aufirst%3DP.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520study%2520of%2520EKB-569%252C%2520an%2520irreversible%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Holm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span> </span><span class="NLM_article-title">DaliLite workbench for protein structure comparison</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">566</span> <span class="NLM_lpage">567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=566-567&author=L.+Holmauthor=J.+Park&title=DaliLite+workbench+for+protein+structure+comparison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolm%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DJ.%26atitle%3DDaliLite%2520workbench%2520for%2520protein%2520structure%2520comparison%26jtitle%3DBioinformatics%26date%3D2000%26volume%3D16%26spage%3D566%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>DaliLite Pairwise Comparison of Protein Structures. <a href="http://www.ebi.ac.uk/DaliLite/" class="extLink">http://www.ebi.ac.uk/DaliLite/</a> (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DaliLite+Pairwise+Comparison+of+Protein+Structures.+http%3A%2F%2Fwww.ebi.ac.uk%2FDaliLite%2F+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDaliLite%2520Pairwise%2520Comparison%2520of%2520Protein%2520Structures" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Agresti, A.</span> <span class="citation_source-book">Logistic Regression. An Introduction to Categorical Data Analysis.</span><span class="NLM_publisher-name">Wiley Interscience</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1996</span>; pp  <span class="NLM_fpage">103</span>− <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=103-144&author=A.+Agresti&title=Logistic+Regression.+An+Introduction+to+Categorical+Data+Analysis."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAgresti%26aufirst%3DA.%26btitle%3DLogistic%2520Regression.%2520An%2520Introduction%2520to%2520Categorical%2520Data%2520Analysis.%26pub%3DWiley%2520Interscience%26date%3D1996%26spage%3D103%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-ref46_1"><span>Logistic Regression. <a href="http://statpages.org/logistic.html" class="extLink">http://statpages.org/logistic.html</a> (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Logistic+Regression.+http%3A%2F%2Fstatpages.org%2Flogistic.html+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref46_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DLogistic%2520Regression" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-ref47_1"><span>Protein Library. <a href="http://protlib.uchicago.edu/dloads.html" class="extLink">http://protlib.uchicago.edu/dloads.html</a>  (accessed May 2008).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Library.+http%3A%2F%2Fprotlib.uchicago.edu%2Fdloads.html+%28accessed+May+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref47_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Library" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITW','PDB','2ITW'); return false;">PDB: 2ITW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PKG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PKG','PDB','1PKG'); return false;">PDB: 1PKG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J7T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J7T','PDB','2J7T'); return false;">PDB: 2J7T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C30" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C30','PDB','2C30'); return false;">PDB: 2C30</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J51" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J51','PDB','2J51'); return false;">PDB: 2J51</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKY','PDB','1OKY'); return false;">PDB: 1OKY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AQ1','PDB','1AQ1'); return false;">PDB: 1AQ1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HZ4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HZ4','PDB','2HZ4'); return false;">PDB: 2HZ4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR','PDB','1NVR'); return false;">PDB: 1NVR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WVY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WVY','PDB','1WVY'); return false;">PDB: 1WVY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITQ','PDB','2ITQ'); return false;">PDB: 2ITQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ITU','PDB','2ITU'); return false;">PDB: 2ITU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DQ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DQ7','PDB','2DQ7'); return false;">PDB: 2DQ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q3D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q3D','PDB','1Q3D'); return false;">PDB: 1Q3D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NRY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NRY','PDB','2NRY'); return false;">PDB: 2NRY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OIC','PDB','2OIC'); return false;">PDB: 2OIC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SM2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SM2','PDB','1SM2'); return false;">PDB: 1SM2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SNU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SNU','PDB','1SNU'); return false;">PDB: 1SNU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ','PDB','1YVJ'); return false;">PDB: 1YVJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPD','PDB','1QPD'); return false;">PDB: 1QPD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPJ','PDB','1QPJ'); return false;">PDB: 1QPJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CLQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CLQ','PDB','2CLQ'); return false;">PDB: 2CLQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GCD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GCD','PDB','2GCD'); return false;">PDB: 2GCD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NXK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NXK','PDB','1NXK'); return false;">PDB: 1NXK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2PZY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2PZY','PDB','2PZY'); return false;">PDB: 2PZY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R0P','PDB','1R0P'); return false;">PDB: 1R0P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7','PDB','2HW7'); return false;">PDB: 2HW7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HY8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HY8','PDB','2HY8'); return false;">PDB: 2HY8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OKZ','PDB','1OKZ'); return false;">PDB: 1OKZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z','PDB','1E8Z'); return false;">PDB: 1E8Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS','PDB','1YHS'); return false;">PDB: 1YHS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IWI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IWI','PDB','2IWI'); return false;">PDB: 2IWI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC','PDB','1STC'); return false;">PDB: 1STC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XJD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XJD','PDB','1XJD'); return false;">PDB: 1XJD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0J','PDB','2J0J'); return false;">PDB: 2J0J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0K','PDB','2J0K'); return false;">PDB: 2J0K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J0M','PDB','2J0M'); return false;">PDB: 2J0M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BYG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BYG','PDB','1BYG'); return false;">PDB: 1BYG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BUJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BUJ','PDB','2BUJ'); return false;">PDB: 2BUJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC','PDB','1XBC'); return false;">PDB: 1XBC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U59" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U59','PDB','1U59'); return false;">PDB: 1U59</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M17','PDB','1M17'); return false;">PDB: 1M17</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHV','PDB','1YHV'); return false;">PDB: 1YHV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GQG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GQG','PDB','2GQG'); return false;">PDB: 2GQG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V7A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V7A','PDB','2V7A'); return false;">PDB: 2V7A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F4J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F4J','PDB','2F4J'); return false;">PDB: 2F4J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQ4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQ4','PDB','1MQ4'); return false;">PDB: 1MQ4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K2P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K2P','PDB','1K2P'); return false;">PDB: 1K2P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JC6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JC6','PDB','2JC6'); return false;">PDB: 2JC6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAM','PDB','2JAM'); return false;">PDB: 2JAM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UNG','PDB','1UNG'); return false;">PDB: 1UNG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57','PDB','1Z57'); return false;">PDB: 1Z57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EU9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EU9','PDB','2EU9'); return false;">PDB: 2EU9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CMW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CMW','PDB','2CMW'); return false;">PDB: 2CMW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C47" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2C47','PDB','2C47'); return false;">PDB: 2C47</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A2A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A2A','PDB','2A2A'); return false;">PDB: 2A2A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J90" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2J90','PDB','2J90'); return false;">PDB: 2J90</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MQB','PDB','1MQB'); return false;">PDB: 1MQB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QO9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QO9','PDB','2QO9'); return false;">PDB: 2QO9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OVC','PDB','1OVC'); return false;">PDB: 1OVC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AGW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AGW','PDB','1AGW'); return false;">PDB: 1AGW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GJO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GJO','PDB','1GJO'); return false;">PDB: 1GJO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RJB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RJB','PDB','1RJB'); return false;">PDB: 1RJB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QCF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QCF','PDB','1QCF'); return false;">PDB: 1QCF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GAG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1GAG','PDB','1GAG'); return false;">PDB: 1GAG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B7A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B7A','PDB','2B7A'); return false;">PDB: 2B7A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UKH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UKH','PDB','1UKH'); return false;">PDB: 1UKH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PMN','PDB','1PMN'); return false;">PDB: 1PMN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QPC','PDB','1QPC'); return false;">PDB: 1QPC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3','PDB','2AC3'); return false;">PDB: 2AC3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JAV','PDB','2JAV'); return false;">PDB: 2JAV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DI9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DI9','PDB','1DI9'); return false;">PDB: 1DI9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CM8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CM8','PDB','1CM8'); return false;">PDB: 1CM8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CDZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CDZ','PDB','2CDZ'); return false;">PDB: 2CDZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F57','PDB','2F57'); return false;">PDB: 2F57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LWP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LWP','PDB','1LWP'); return false;">PDB: 1LWP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YXT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YXT','PDB','1YXT'); return false;">PDB: 1YXT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GU8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GU8','PDB','2GU8'); return false;">PDB: 2GU8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ETM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ETM','PDB','2ETM'); return false;">PDB: 2ETM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VZO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VZO','PDB','1VZO'); return false;">PDB: 1VZO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SRC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SRC','PDB','2SRC'); return false;">PDB: 2SRC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBB','PDB','1XBB'); return false;">PDB: 1XBB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVR','PDB','1FVR'); return false;">PDB: 1FVR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U46" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U46','PDB','1U46'); return false;">PDB: 1U46</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P2H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P2H','PDB','2P2H'); return false;">PDB: 2P2H</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a href="/doi/suppl/10.1021/jm800453a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66517"></div></div></div></div></div><hr /></hr><p class="last">Wrapping comparison, predicted affinity profile, and experimental screening of <b>9</b> against 56 PDB-reported kinase structures (Methods). Synthesis and spectroscopic characterization of compounds <b>9</b> and <b>10</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800453a/suppl_file/jm800453a-file002.pdf">jm800453a-file002.pdf (442.79 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800453a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-16%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm800453a" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800453a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a73349ead198b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
